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ABSTRACT 
 
 
MOLECULAR MECHANISMS OF SLEEP/WAKE REGULATION AND 
MEMORY FORMATION IN YOUNG AND AGED MICE 
 
Mathieu Eugene Wimmer 
Advisor: Ted Abel 
Advancements in healthcare and medicine have greatly increased lifespan. Normal 
aging is accompanied by deterioration of key physiological processes, including sleep 
and cognition. Understanding the mechanisms by which these functions go awry with 
age is a critical step in identifying novel therapeutic strategies to improve quality of life 
for the elderly. One of the most prevalent complaints in the elderly is the deterioration of 
sleep/wake patterns, difficulties staying awake and reduced vigilance. Little is known 
about the molecular mechanisms controlling these states in the brain. Mouse models are 
ideally suited to address this question because they share many similarities with human 
biology and afford the ability to manipulate molecular pathways in vivo. In Chapter 2, we 
use polysomnography and conditional mutant animals to explore the molecular 
underpinnings involved in the maintenance of wakefulness. Our results indicate that the 
activity-dependent transcription factor cAMP response element binding protein (CREB) 
is critical in forebrain neurons for the maintenance of wakefulness. Interestingly, aging 
also reduces the ability to sustain wakefulness in the elderly. In Chapter 3, we use 
polysomnography in young and aged mice, combined with a novel statistical approach to 
closely examine how aging impacts the microstructure of sleep and wakefulness. We 
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show that aging specifically impairs the ability to sustain long episodes of wake and non-
rapid eye movement (NREM) sleep. Another major health concern for older individuals is 
the decline of cognitive function. In Chapter 4, we use object-based memory paradigms 
to investigate memory formation in aged mice. Object-based tasks are ideally suited for 
these studies because they circumvent the confounding alterations in motor function and 
stress response that accompany aging. We show that aging impairs the consolidation of 
memories related to the location of objects in space. Our findings indicate that the 
hippocampus, a brain region critical to spatial memory, is particularly vulnerable to 
aging. Taken together, our findings outline the molecular pathways involved in the 
regulation of sleep and wake and lay the groundwork for further understanding of how 
these systems are altered in the aged brain.  
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Chapter 1. Introduction. 
This thesis focuses on the molecular mechanisms controlling the regulation of 
sleep/wake states and memory formation and how these processes are altered by aging. 
In this Chapter, I will first discuss some of the ways investigators have mapped the 
neural circuits that control sleep and wake. I will then provide some background on 
cAMP response element binding protein (CREB) family transcription factors and how 
CREB signaling relates to memory formation and sleep. Lastly, I will introduce some of 
the problems facing the elderly, including the deterioration of sleep/wake patterns and 
cognitive decline.  
Measuring sleep/wake patterns in the laboratory. Sleep is a highly evolved global 
behavioral state and mammals spend anywhere from one-third to one-half of their lives 
asleep, depending on the species. Sleep can be defined as a reversible state 
characterized by behavioral quiescence and a heightened arousal threshold. Sleep is 
not a unitary event. It consists of alternating periods of non-rapid eye movement (NREM) 
and rapid eye movement (REM) sleep. These two states can be differentiated using 
measures of brain and muscle activity and autonomic functions such as heart rate and 
respiration. Polysomnography is the most common method used to measure sleep/wake 
and it combines electroencephalography (EEG), the recording of brain activity with 
electromyography (EMG), the recording of neck muscle activity (Franken et al., 1991; 
Franken et al., 1999; Pace-Schott and Hobson, 2002; Datta and Maclean, 2007). EEG 
measures large-scale patterns of activity in the brain with millisecond resolution (Figure 
1.1). NREM sleep, which is sometimes referred to as slow wave sleep, is characterized 
by high amplitude, low frequency (1-4Hz) waves. The amplitude of these EEG 
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oscillations, referred to as “delta” waves, is indicative of extensive synchrony of neuronal 
firing during NREM sleep and this phenomenon is widely used as a marker of sleep 
intensity and sleep pressure. Slow wave activity (SWA, the power in the delta 1-4Hz 
range during NREM sleep), is highest after periods of extended wakefulness and is 
discharged over the course of sleep (Borbely et al., 1981; Borbely, 2001; Franken et al., 
2001). The exact function of these delta waves remains unknown but some evidence 
suggests that they are functionally relevant for memory formation (Marshall et al., 2004).  
In contrast, waking and REM sleep show high frequency, low amplitude patterns of EEG 
activity. One major difference between these two states is that REM sleep is 
accompanied by loss of muscle tone (i.e., atonia), which can be visualized using EMG. 
Another hallmark of REM sleep, as its name indicates, are rapid eye movements, which 
can be detected using electrooculography (EOG). However, EOG recordings are not 
required to identify REM sleep and they are not common in the rodent laboratory setting. 
Major differences exist between human and rodent sleep. First, mice and rats are 
nocturnal and sleep mostly during the light (rest) phase. Secondly, human sleep is more 
consolidated and rodents show many more transitions between states, often referred to 
as “bouts”. The most consolidated period for rodents occurs during the first ~4 hours of 
the dark phase, when animals show extended bouts of wakefulness that can last several 
hours. On the other hand, the neurobiology regulating sleep/wake states is similar in 
human and rodents and much has been learned about how the brain controls these 
states using animal models.  
 
Neurobiological mechanisms controlling sleep/wake behavior. Mapping of the 
neural circuits that control wakefulness and sleep began nearly 100 years ago when the 
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neurologist Constantine Von Economo described a series of unusual cases of 
Encephalitis Lethargica (EL) after World War I in the journal Wiener Klinische 
Wochenschrift (1917). Von Economo identified 3 distinct clinical patterns of EL: 1) the 
somnolent-opthalmoplegic EL caused extreme sleepiness followed by coma and often 
death, 2) the hyperkinetic form was characterized by insomnia and restlessness and 3) 
the amyostatic-akinetic appeared to be related to Parkinsonism, with weakness, rigidity 
and bradykinesia.  Post-mortem, Von Economo carefully studied the location of lesions 
in these patients and outlined which brain regions were likely to be critical for the 
regulation of sleep and wakefulness. Based on his histopathological observations, Von 
Economo defined the preoptic area as important for sleep, as lesions to this “sleep” area 
caused insomnia. In contrast lesions to the posterior hypothalamus (“waking” region) 
induced sleep and heightened arousal thresholds. Von Economo’s original observations 
have been refined over time and much has been learned in the past 60 years about the 
specific systems that influence sleep/wake. Recent electrophysiological and behavioral 
studies have led to an improved understanding of the neurochemicals, pathways, and 
cell firing patterns that regulate these states. The “waking” and “sleep” regions are 
composed of complex mutually inhibitory networks of neurons that integrate circadian 
and homeostatic inputs to produce sleep/wake patterns (Datta and Maclean, 2007).  
Activation of the wake-promoting system in the brain produces arousal and inhibits the 
initiation of sleep. The state of wakefulness is a complex coordinated expression of 
behaviors that are regulated by many neurochemically defined cells groups: 1) 
noradrenergic neurons in the locus Coereleus (LC), 2) orexinergic (hypocretin) cells in 
the lateral hypothalamus (LH) 3) serotonergic (5-HT) cells in the raphe nuclei (RN), 4) 
cholinergic (Ach) neurons in the pedunculopontine tegmentum (PPT), 5) dopaminergic 
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(DA) cells in the substantia nigra compacta (SNc) and ventral tegmental area (VTA), 6) 
cholinergic and glutamatergic neurons of the basal forebrain (BF). Projections from 
these pontine and midbrain wake-promoting cells travel dorsally to activate 
thalamocortical pathways as well as ventrally to activate hypothalamo-cortical and 
basalo-cortical systems (Garcia-Rill et al., 2004; Skinner et al., 2004; Morgane et al., 
2005).  
LC noradrenergic neurons have long been associated with arousal and attention. LC 
cells fire maximally during wake and LC firing precedes the onset of wakefulness (Aston-
Jones and Bloom, 1981; Foote et al., 1983; Takahashi et al., 2010), suggesting that 
these neurons are critical for the initiation of wakefulness, particularly out of NREM sleep 
(Takahashi et al., 2010). LC projects directly to the cortex and maximum levels of 
spontaneously released norepinephrine (NE) in the forebrain and cerebral cortex occur 
during wake (Florin-Lechner et al., 1996; Berridge and Abercrombie, 1999). In addition, 
direct activation of LC produces arousal and EEG de-synchronization consistent with 
wakefulness (Berridge and Foote, 1991; Berridge et al., 1993; Berridge and Foote, 
1996).  
Orexin/hypocretin neurons, which are localized to the LH (de Lecea et al., 1998; Peyron 
et al., 1998), project directly to cerebral cortex and broadly throughout the brain. 
Importantly, orexin cells heavily innervate many of the wake promoting brain regions, 
including the PPT, LC, RN, SNc, and VTA (Peyron et al., 1998; Nambu et al., 1999; 
Taheri et al., 1999) and application of orexin to these areas is excitatory (Hagan et al., 
1999; Bourgin et al., 2000; Takahashi et al., 2002). Orexin cells are more active during 
wakefulness than during sleep (Alam et al., 2002; Koyama et al., 2003) and extracellular 
levels of orexin are highest during wake (Kiyashchenko et al., 2002; Zeitzer et al., 2003). 
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Thus, orexin signaling is thought to be important for the maintenance of wakefulness. 
Consistent with this hypothesis, ablation and genetic deletion of orexin cells or orexin 
receptors causes narcolepsy and stimulation of orexin neurons produces wakefulness 
(Chemelli et al., 1999; Hara et al., 2001; Adamantidis et al., 2007).  
5-HT neurons of the RN project to the forebrain and cerebral cortex (Consolazione et al., 
1981; Tork, 1990) and fire maximally during wakefulness (Lydic et al., 1983). The 
literature regarding the role of these neurons in the regulation of sleep/wake is mixed, 
with some reports suggesting that 5-HT promotes sleep (Petitjean et al., 1978; Datta et 
al., 1987; Cape and Jones, 1998) and other studies indicating that 5-HT is important for 
the maintenance of wakefulness (Monti and Jantos, 1992; Ponzoni et al., 1993; Boutrel 
et al., 2002). Thus, serotonergic cells in the RN may be involved in the regulation of both 
wakefulness and NREM sleep via processes that remain to be elucidated.  
Single unit recordings from Ach PPT neurons across sleep/wake revealed the presence 
of at least 4 cell types: 1) REM-on, 2) Wake-REM-on, 3) Wake-on and 4) sleep-wake 
unrelated (Saito et al., 1977; el Mansari et al., 1990; Steriade et al., 1990; Datta, 1995). 
These findings suggest that the PPT is involved in promoting both wakefulness and 
REM sleep. Consistent with this interpretation, stimulation of PPT induces wakefulness 
and REM sleep (Datta and Siwek, 1997; Datta et al., 2001). Cholinergic cells of the PPT 
do not directly project to cerebral cortex (Datta, 1995), but stimulation of PPT promotes 
wakefulness by activating thalamo-cortical, hypothalamo-cortical and basalo-cortical 
pathways (Datta, 1997).  
DA neurons located in the SNc and VTA heavily innervate the frontal cortex and basal 
forebrain (Hillarp et al., 1966; Freeman et al., 2001; Jones, 2005), where extracellular 
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levels of DA are highest during wake states (Trulson, 1985; Smith et al., 1992; Feenstra 
et al., 2000). In addition, injection of dopamine receptor agonists induces wakefulness at 
the expense of NREM and REM sleep (Monti et al., 1990; Isaac and Berridge, 2003). 
Conversely, dopamine antagonist injections and genetic deletion of D2 dopamine 
receptors reduce wakefulness (Monti et al., 1990; Trampus et al., 1991; Qu et al., 2010). 
Thus, besides their well established role in driving motivated behaviors (Grace et al., 
1998), dopaminergic cells are also an important component of the wake promoting 
system. 
The BF contains cholinergic and glutamatergic neurons that can activate cortical 
pyramidal cells either directly or indirectly, causing EEG desynchronization (Jones, 
2004). Many of the BF neurons are most active during wake and their activity pattern 
matches with specific EEG rhythms. Consistent with these observations, lesions of the 
BF either result in slowing of the EEG or in reduced levels of wakefulness (Kaur et al., 
2008). Acute manipulations inhibiting or activating BF produce NREM sleep and 
wakefulness, respectively (Cape and Jones, 2000).  
Opposing the arousal system, is a group of inhibitory neurons in the ventrolateral 
preoptic area (VLPO), that send projections to wake promoting nuclei (Sherin et al., 
1998). VLPO also receives inputs from the arousal system and VLPO neurons are 
inhibited by NE, 5-HT, DA and Ach (Gallopin et al., 2000; Gallopin et al., 2004). Firing of 
VLPO cells is highest during sleep, with some neurons firing preferentially prior to the 
onset of and during NREM sleep and other sub-populations firing preferentially at the 
onset and during REM sleep (Takahashi et al., 2009). Furthermore, lesions to VLPO 
reduces NREM and REM sleep by about 50% (Lu et al., 2000; Lu et al., 2006), indicating 
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that other regions in the brain are also required for promoting sleep. Some of these cells 
are located in the pons and are known to drive REM sleep (Datta, 1995).  
Current models of sleep/wake regulation postulate that interactions between wake- and 
sleep-promoting systems can be modeled as a “flip-flop” switch, where transitions 
between states are rapid and dependent upon one side overpowering the other (Saper, 
2006; Saper et al., 2011). Thus, firing of cortical neurons is controlled by the flip-flop 
switch with homeostatic and circadian influences (Borbely, 1982), and these systems 
ultimately dictate the behavioral state of the animal. The work described in Chapter 2, 
explores the molecular mechanisms within the FB and the LC that are involved in the 
maintenance of wakefulness. Experiments in Chapter 3 examine how aging impacts the 
regulation of sleep/wake states and which nuclei in the brain are likely to be altered in 
the aged brain.  
 
The function and regulation of cAMP response element binding protein (CREB) 
family transcription factors. Several vital functions in mammals require the ability of 
cells to properly communicate with their environment. The conversion of extracellular 
stimuli into signals promoting cell growth, survival or death is largely orchestrated by 
changes in gene expression. In the brain, these processes not only regulate 
development in early life, but also continue to mold the connections between neurons 
that are at the root of many essential behaviors and physiological processes in the 
mature nervous system. Extensive studies of the CREB family of transcription factors 
have revealed that signaling cascades involving CREB-related proteins are key 
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mediators of activity-dependent nuclear responses underlying development, proper 
function and plasticity of the nervous system.  
CREB belongs to the basic leucine zipper (bZIP) family of transcription factors, which 
includes the closely related transcription factors cAMP response element modulator 
(CREM), and activating transcription factor 1 (ATF-1).  The bZIP domain facilitates 
homo-dimerization and hetero-dimerization of CREB family transcription factors, a 
requirement for DNA binding to cAMP response element (CRE) sites (TGACGTCA). 
CRE sites are found within the regulatory region of numerous genes, many of which are 
subject to regulation by CREB. CREB-mediated transcription is activated in response to 
a vast array of physiological stimuli, which are transduced through a variety of signaling 
cascades.  
One of the best studied mechanisms activating CREB-mediated transcription is the 
phosphorylation of CREB at serine-133 (pCREB), which promotes the recruitment of co-
activators such as CREB binding protein (CBP) and the interaction with the 
transcriptional machinery. This serine residue of CREB can be phosphorylated by the 
cAMP/PKA pathway, calcium signaling and Ca2+ calmodulin kinases (CaM kinases), as 
well as the mitogen activated protein kinase (MAPK) pathway (Gonzalez and Montminy, 
1989; Dash et al., 1991; Sheng et al., 1991; Xing et al., 1996; De Cesare et al., 1998; 
Deak et al., 1998; Xing et al., 1998). CREB-mediated transcription can also be induced 
through phosphorylation-independent mechanisms. CREB-regulated transcription 
coactivator (CRTCs) interact with the bZIP domain of CREB and can influence 
transcription (Conkright et al., 2003; Takemori et al., 2007; Xu et al., 2007). CRTC-
CREB interaction requires phosphorylation of CRTC by salt inducible kinase (SIK) and 
shuttling of CRTC to the nucleus. It is thought that these many layers of regulation 
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permit the broadly expressed CREB transcription factor to serve such a wide array of 
functions in different cell types.  
Researchers have developed extensive genetic tools to experimentally alter and 
manipulate CREB signaling and CREB-mediated gene transcription. Constitutive and 
conditional knock out of CREB have been widely used to study CREB function in the 
nervous system (Hummler et al., 1994; Mantamadiotis et al., 2002). Another example is 
the dominant-negative form of CREB CREBM1 (mCREB), where serine 133 has been 
replaced by an alanine residue. This mutation prevents phosphorylation without 
interfering with the ability of mCREB to dimerize with endogenous CREB family 
transcription factors, or with the ability of dimers to bind DNA (Gonzalez and Montminy, 
1989; Chrivia et al., 1993; Kwok et al., 1994). Thus mCREB reduces transcription of 
CREB target genes by interfering with recruitment of co-activators and transcriptional 
machinery. KCREB is another dominant-negative mutant form of CREB, which harbors a 
point mutation in the DNA-binding domain. Thus, KCREB reduces gene expression by 
titrating wild-type CREB and interfering with DNA binding (Pittenger et al., 2002). In 
contrast, constitutively active forms of CREB, such as CREB-VP16, have also been 
engineered. This mutant form of CREB can heterodimerize with endogenous CREB 
proteins and activate transcription in the absence of serine 133 phosphorylation (Barco 
et al., 2002). These molecular tools have led to a vastly improved understanding of both 
the regulation and the functions of CREB signaling.  
CREB is best known for its involvement in memory formation and synaptic plasticity. 
Studies in Aplysia (sea slug), Drosophila (fruit fly) and rodents indicate that CREB is 
required for long-term memory consolidation (Kaang et al., 1993; Bourtchuladze et al., 
1994; Kwok et al., 1994; Yin et al., 1994; Graves et al., 2002), the process by which 
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labile short-term memories are stabilized into long-term traces. Presumably, CREB 
signaling facilitates memory formation through the induction of synaptic plasticity 
(Bourtchuladze et al., 1994; Cha-Molstad et al., 2004; Marie et al., 2005), although the 
exact mechanisms underlying the ability of CREB to promote memory formation are not 
completely understood. CREB function is likely important in the hippocampus and in the 
amygdala to support memory formation. In other brain regions, such as the LC, striatum, 
and the VTA, CREB activity has been linked to reward and the development of drug 
addiction (Barrot et al., 2002; Walters et al., 2003; Carlezon et al., 2005; Parlato et al., 
2010). Another important role of CREB is in the development of depression and anxiety 
(Chen et al., 2001; Barrot et al., 2002). The experiments described in Chapter 2 build 
upon the literature suggesting that CREB signaling is also involved in the maintenance 
of wakefulness. These studies are aimed at uncovering where in brain CREB is required 
for the regulation of sleep and wakefulness.  
 
Aging, sleep and memory formation. Improvements in healthcare have greatly 
increased life expectancy worldwide. Within the US alone, it is estimated that 20% of the 
population will be over the age of 65 years by 2030 (Kinsella, 2001). By 2050, older 
adults will likely outnumber children under age 15 (Cohen, 2003). Importantly, normal 
aging is accompanied by deterioration of key physiological processes including 
cognition, motor behavior, stress response and sleep. Given the growing senior 
population, understanding the mechanisms by which these functions go awry with age is 
a critical step in identifying novel therapeutic strategies and to increase quality of life for 
the elderly.  
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One of the most significant problems facing older individuals is the deterioration of 
sleep/wake patterns. Aged individuals report difficulties falling and staying asleep, as 
well as early awakenings. These changes during the night are also accompanied by 
increased napping and sleepiness during the day (Dijk et al., 1989; Ehlers and Kupfer, 
1989; Bliwise, 1993; Prinz, 1995; Landolt et al., 1996; Dijk et al., 2000). In Chapter 3, we 
explore age-related changes in sleep and wakefulness in mice using a novel statistical 
approach designed to detect small changes in the organization of sleep and wake 
states.  
The deterioration of memory formation is another major concern for the elderly 
population. Memory is one of the earliest cognitive functions to show decline during 
normal aging. Age-associated memory impairment (AAMI), a condition that excludes all 
other causes (i.e. neurodegenerative diseases) other than aging, is prevalent (over 40%) 
(Larrabee and Crook, 1994). Episodic memory, a type of declarative memory that 
depends on the ability to remember facts in a determined temporal and spatial context, 
is especially vulnerable to normal aging (McIntyre and Craik, 1987). Related to episodic 
memory, spatial memory and spatial navigation are also particularly sensitive to the 
deleterious effects of aging. Both types of memories require the hippocampus and 
evidence from the past 20 years suggest that altered hippocampal function is a key 
component of age-related memory decline (Miller and O'Callaghan, 2005). Early reports 
suggested that cell loss was to blame for cognitive decline. However, recent work 
indicates that alterations of intracellular signaling pathways and synaptic connections 
cause memory decline with age. Many of the processes involved in memory formation 
are altered by aging in the brain. Calcium buffering as well as the activity of CaM 
kinases, PKA and CREB change with age (Foster et al., 2001; Karege et al., 2001a; 
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Karege et al., 2001b; Countryman and Gold, 2007; Toescu, 2007; Toescu and 
Vreugdenhil, 2010). In Chapter 4, we use object-based tasks to investigate the effects of 
aging on memories that require hippocampal function.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13
 
Figure 1.1. EEG and EMG recordings from mice. Typical polygraphic appearance of 
wakefulness (top), NREM sleep (middle) and REM sleep (bottom panel) in the adult 
mouse. During wakefulness, cortical EEG presents de-synchronized low amplitude, 
high-frequency waves, a sign of cortical activation and EMG tone. NREM sleep is 
characterized by high-amplitude, low frequency waves with muscle tone still present, but 
reduced compared to wakefulness. During REM sleep, cortical EEG is activated similarly 
to wake EEG but EMG show marked reduction or absence of muscle tone (atonia).  
 
Figure 1.2 Activation of CREB signaling via phosphorylation of Serine 133. 
Calcium (Ca2+) binds calmodulin (CaM) protein and Ca2+/CaM activates CaM kinase IV 
(CaMKIV), a part of the calcium calmodulin kinase (CaMK) cascade. Upon activation, 
nuclear CaMKIV phosphorylates CREB induces gene transcription. Ca2+ signaling also 
leads to CREB phosphorylation by activation of the MAPK/ERK pathway. G protein 
coupled receptors activate adenylyl cyclase, increasing cAMP levels, which results in 
PKA-mediated phosphorylation of CREB.  
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Chapter 2. CREB is Required in Forebrain Neurons to 
Sustain Wakefulness 
Abstract 
Although our understanding of sleep/wake regulation at the systems level has advanced 
over the past 50 years, little is known about the molecular and intracellular signaling 
processes that control sleep/wake states. A consistent observation is that the cyclic-
AMP response element binding protein (CREB), an activity-dependent transcription 
factor, is differentially activated during sleep and wakefulness. CREB is phosphorylated 
by the cyclic AMP/protein kinase A (cAMP/PKA) signaling pathway as well as other 
kinases and phosphorylated CREB (pCREB) promotes transcription of target genes. 
Genetic studies in flies and mice suggest that CREB signaling influences sleep/wake 
states by promoting and stabilizing wakefulness. However, it remains unclear where in 
the brain CREB is required to drive wakefulness. In rats, CREB phosphorylation 
increases in the cerebral cortex during wakefulness and decreases during sleep, but it is 
unclear whether this change is functionally relevant to the maintenance of wakefulness 
or the drive to sleep. Here, we used the cre/lox system to conditionally delete CREB in 
the Locus Coereleus (LC) and in the forebrain, two regions known to be important 
arousal and wakefulness. We used polysomnography to measure sleep/wake levels and 
architecture in conditional CREB mutant mice and control littermates. We found that 
forebrain-specific deletion of CREB decreased wakefulness and increased non-rapid eye 
movement (NREM) sleep. In addition, mice lacking CREB in the forebrain were unable 
sustain normal periods of wakefulness. Forebrain specific CREB conditional knock out 
mice showed similar sleep rebound following a brief period of sleep deprivation. On the 
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other hand, deletion of CREB from LC neurons did not change sleep/wake levels or 
sleep/wake microstructure. Taken together, these results suggest that CREB is required 
in neurons within the forebrain to promote and stabilize wakefulness.  
 
Introduction 
Mapping of the neural circuits that control wakefulness and sleep began over 50 years 
ago and much has been learned in the past 10-20 years about the specific systems that 
influence sleep/wake. Recent electrophysiological and behavioral studies have led to an 
improved understanding of the neurochemicals, pathways, and cell firing patterns that 
regulate these states. Wake promoting regions such as the locus Coereleus (LC) (Aston-
Jones and Bloom, 1981) send projections to the cerebral cortex and activity in these 
regions produces EEG de-synchronization consistent with arousal and wakefulness 
(Berridge and Foote, 1991). This arousal producing system is balanced by sleep-
promoting areas, which induce sleep and suppress wakefulness (Lu et al., 2000). These 
two mutually inhibiting systems act in concert with circadian and homeostatic processes 
to regulate sleep/wake states. However, little is known about the intracellular processes 
underlying sleep/wake regulation. Genetic and imaging studies have identified the CREB 
signaling pathway and CREB-regulated transcription as potential mechanisms of 
sleep/wake regulation. It is well established that the CREB transduction pathway is 
involved in synaptic plasticity and memory formation (Silva et al., 1998; Abel and Lattal, 
2001; Lonze and Ginty, 2002; Carlezon et al., 2005; Alberini, 2009; Benito and Barco, 
2010; Josselyn, 2010). CREB signaling is also essential to the proper regulation of 
sleep/wake states. Mice lacking two isoforms of CREB show reduced wakefulness and 
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increased sleep (Graves et al., 2003b). In flies, CREB activity is inversely related to rest 
(Hendricks et al., 2001). However, it is unclear where in the brain CREB plays a critical 
role to sustain wakefulness. CREB activity and expression of CREB downstream target 
genes are increased in the cortex following periods of wakefulness (Cirelli and Tononi, 
2000). These changes in the cortex require inputs from the LC (Cirelli et al., 1996) and 
mice lacking dopamine beta hydroxylase (DBH), the enzyme required for norepinephrine 
synthesis, show reduced wakefulness and wake fragmentation (Ouyang et al., 2004). 
Taken together, these studies suggest that CREB may be required in the cortex and/or 
in the LC to promote and stabilize wakefulness. We used conditional knock out 
approaches to determine where CREB is required to sustain wakefulness.    
 
Methods  
Animals. Forebrain CREB cKO (FB CREB cKO) mice were obtained by crossing 
animals expressing Cre recombinase driven by the CaMKIIα promoter (Dragatsis and 
Zeitlin, 2000) to mice carrying a floxed allele of Creb1 (Mantamadiotis et al., 2002). Mice 
lacking CREB in noradrenergic neurons were obtained by crossing mice expressing cre 
recombinase driven by the dopamine beta hydroxylase (DBH) promoter (Parlato et al., 
2010) to mice carrying a floxed allele of Creb1 (Mantamadiotis et al., 2002). All lines 
were backcrossed to C57Bl/6J. Experimental CREB conditional knock out animals were 
male and female mice homozygous for the floxed Creb1 allele and hemizygous for the 
cre transgene. Control mice were either hemizygous for cre recombinase or carried 
floxed alleles of Creb1.  Animals were maintained on a 12 hour light/12 hour dark cycle 
with lights on (ZT 0) at 7:00 am. Food and water were available ad libitum. All animal 
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care and experiments were approved by the Institutional Animal Care and Use 
Committee of the University of Pennsylvania and conducted in accordance with the 
National Institute of Health guidelines.  
 
Surgery. Animals were implanted with EEG and EMG electrodes under isoflurane 
anesthesia. Electrodes were held in place with dental cement (Ketac, 3M, St Paul, MN). 
Electrodes consisted of Teflon coated wires (Cooner wires, Chatsworth, CA) soldered to 
gold socket contacts (Plastics One, Roanoke, VA) and pushed into a 6-pin plastic plug 
(363 plug, Plastics One). The contacts were cemented to the plug using dental cement. 
Animals were connected to amplifiers using light-weight cables (363, Plastics One) 
attached to a rotating commutator (SLC6, Plastics One). All recordings were obtained 
using a parietal electrode (ML ±1.5mm from Bregma, AP +2mm from Lambda) 
referenced to an electrode over the cerebellum (1.5 mm posterior of Lambda). Mice 
were allowed to recover from surgery for a minimum of 2 weeks. During the second 
week of recovery, mice were acclimated to the cables and to the recording chambers.  
 
EEG recordings and analysis. EEG/EMG signals were recorded over a 24-hour 
baseline period, during which animals were undisturbed. The next day, animals were 
sleep deprived (SD) for 6 hours, starting at lights on (ZT 0) using gentle handling 
(Vecsey et al., 2009) and allowed to recover for 18 hours. EEG/EMG signals were 
sampled at 256 Hertz (Hz) and filtered at 0.5-30Hz and 1-100Hz, respectively with 12A5 
amplifiers (Astro-Med, West Warwick, RI). Data acquisition and visual scoring was 
performed using SleepSign software (Kissei Comtec, INC, Japan). EEG/EMG recordings 
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were scored in 4 second epochs as wake, NREM, or REM by a trained experimenter 
blind to genotype. Epochs containing movement artifacts were included in the state 
totals and architecture analysis, but excluded from subsequent spectral analysis. 
Spectral analysis was performed using a fast Fourier transform (FFT; 0.5-20Hz, 0.125Hz 
resolution). EEG spectra were computed over 24 hours. NREM EEG spectra were also 
computed in 2 hour windows for the baseline and SD periods. NREM slow wave activity 
(SWA), was normalized to the last 4 hours of the light phase of the baseline day for each 
animal as previously described (Franken et al., 2001).  
 
Immunohistochemistry. Mice were anesthetized with isoflurane and transcardially 
perfused with ice cold PBS, followed by ice cold 4.0% paraformadelhyde using a 
peristaltic perfusion pump (Rainin Instruments, Oaklan, CA). Fixed brains were 
dissected, postfixed overnight and cryoprotected in 30% sucrose. Brains were frozen 
and cryosectioned coronally at a thickness of 30 um into PBS. Floating sections were 
blocked for 1 hour at room temperature in 2% normal donkey serum (NDS, Vector 
Laboratories, Burlingame, CA) in 0.3% Triton X-100 PBS. Sections were first processed 
for CREB-immunostaining with nickel ammonium sulfate intensification of DAB and then 
processed for tyrosine hydroxylase (TH). Sections were incubated overnight at 4C in 2% 
NDS, 0.1% Titon X-100 in PBS with anti-CREB primary antibody (1:3,000; 9197 Cell 
Signaling, Danvers, MA), 2 hours at room temperature with biotynalated donkey anti-
Rabbit secondary antibody in 0.1% Triton X-100 PBS (1: 500; Jacskon Immunoresearch, 
Newmarket Suffolk, England) and 1.5 hours at room temperature with ABC in 0.1% 
Triton X-100 (1:500; Vector Laboratories, Burlingame, CA). Sections were washed 3 x 
10 minutes with PBS between each incubation. The same procedure was followed for 
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TH immunostains using anti-TH antibody (1:10,0000, Millipore, Billerica, MA). For 
fluorescent immunohistochemistry, FITC-conjugated anti-rabbit IgG secondary antibodie 
(1:1000, Chemicon, Temecula, CA) were used. Sections were mounted on slides and 
imaged using a microscope or confocal microscope. Cell counting and optical density 
measurements were conducted using ImageJ. 6 sections (3 from each side) from 3-4 
animals were used for all quantifications of CREB levels.  
Quantitative real-time PCR. Cortex samples were collected into 500 uL of RNAlater 
(Ambion, Austin, TX) at ZT16 and flash frozen. All collections were done under red light 
to avoid any potential light pulse effects. The list of transcripts examined was based on 
previous reports showing that CREB is required for the expression of these genes 
(Lemberger et al., 2008). Preparation of mRNA and cDNA synthesis were conducted as 
previously described (Vecsey et al., 2007). PCR reactions were prepared in 96-well 
optical reaction plates (Applied Biosystems, Foster City, CA). Each well contained 10 uL 
of cDNA and 1uL of of Taqman probes  and 9 uL of Taqman Fast Universal PCR Master 
Mix (Applied Biosystems, Foster City, CA). 6 biological and 3 technical replicates were 
used. Data were normalized to Hprt1 (probe ID Mm0145399-m1, Tuba4a 
(Mm00849767-S1) and Gapdh (Mm99999915_g1). Fold change was calculated from the 
ΔCt cycle threshold values with corrections for standard curve data from each gene and 
housekeeping gene expression levels for each sample.  For each sample, ΔCt was 
calculated against the mean for the sample set of that gene. Next, each of these values 
was corrected with the slope of the standard curve for the relevant probe to account for 
efficiency. This corrected value was normalized to the ΔCt from housekeeping genes for 
each sample to account for input variability. Fold change is equal to two raised to the 
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difference between experimental and control Ct values. Student’s t-tests were used to 
compare groups.  
 
Statistics. Student’s t-tests were used to compare wake, NREM and REM sleep levels 
averaged over 24 hours. Multivariate analysis of variance (MANOVA) was used on the 
proportion of time spent in each state during the light phase, the dark phase and during 
the 8 x 3-hour time points across 24 hours, followed by Tukey studentized range tests to 
compare genotype groups. The same procedure was applied to the number of bouts and 
the average bout duration to compare groups. MANOVA was also used to compare the 
difference in total sleep time, NREM and REM sleep between the baseline and recovery 
periods following 6 hours of SD. Tukey studentized range tests were used to analyze 
raw EEG spectra for wake, NREM and REM sleep. Student’s t-tests were used to 
analyze theta peak frequency for wake and REM EEG spectra. NREM SWA during the 4 
x 2-hour bins was analyzed using repeated measures ANOVA followed by Tukey 
studentized range tests.  
 
Results 
CREB is required in the forebrain to sustain wakefulness. Forebrain CREB 
conditional knock out mice (FB CREB cKO) were generated by crossing a Cre-
expressing line driven by the CaMKIIα promoter (Dragatsis and Zeitlin, 2000) to animals 
carrying a floxed allele of Creb1 (Mantamadiotis et al., 2002) (Figure 2.1A). We 
quantified levels of CREB using optical density measurements of sections immuno-
stained for CREB. CREB protein levels were reduced by 66% in FB CREB cKO 
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(p=0.005, Figure 2.1B-F). Expression of Creb1 was markedly reduced in the cortex of FB 
CREB cKO animals (Table 2.1). Expression of CREB target genes Nr4a1 and Gadd45b 
were also decreased. In contrast, expression of cAMP  response element modulator 
(CREM), another member of the same family of transcription factors was increased in 
conditional CREB mutant animals (Table 2.1), consistent with results in other CREB 
mutant models. We used EEG/EMG recordings to measure wake, non-rapid eye 
movement (NREM) and rapid eye movement (REM) sleep in conditional CREB mutant 
animals and control littermates. During the 24 h baseline period, animals were 
undisturbed and recording began at lights on (ZT0). FB CREB cKO animals showed 
decreased wakefulness over 24 hours (F(2,45)=11.39, p<0.0001) and during both the 
light and the dark periods (Figure 2.2A , F(4,88)=6.32, p=0.0002). Decreased 
wakefulness was accompanied by increased NREM sleep in FB CREB cKO compared 
to control (F(2,45)=11.18, p<0.0001) over 24 hours and during the light and dark periods 
(Figure 2.2B, F(4,88)=6.09,p=0.0002). REM sleep levels were unchanged over 24 hours 
(F(2,45)=2.59, p=0.09). However, REM levels increased in FB CREB cKO animals 
during the dark phase (Figure 2.2C, F(4,88)=2.58, p=0.04). Multivariate analysis of 
variance (MANOVA) revealed that FB CREB cKO animals have decreased wakefulness 
across the light/dark cycle (Figure 2.2D, F(16,76)=2.71, p =0.0.0019). We used Dunnett 
post-hoc comparisons to compare groups in 3 hour bins across the day (Figure 2.2 D-F) 
and found that the effect of genotype on wakefulness differs across time (Figure 2.2D). 
NREM sleep was also increased at several time points in FC CREB cKO animals (Figure 
2.2E, F(16,76)=2.66, p=0.0023). REM sleep was only increased in FB CREB cKO during 
the active (dark) period (Figure 2.2F, F(16,76)=2.19, p=0.0123). These results suggest 
that CREB is required in the forebrain for appropriate levels of wakefulness.   
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CREB is required in the forebrain to sustain wakefulness. To determine the nature 
of the reduction in wakefulness, we examined the architecture or wake, NREM and REM 
sleep by computing the number of bouts and the average duration of these events in 
each state. FB CREB cKO mice showed an increased number of wake bouts during the 
light and dark phase (Figure 2.3A, F(4,86)=10.64,p<0.0001). In addition, the average 
duration of wake bouts was reduced in FB CREB cKO mice (Figure 2.3B, F(4,86)=13.74, 
p<0.0001). The number of NREM bouts increased in FB CREB cKO (Figure 2.3C, 
F(4,86)=4.37, p=0.0029). However, the average duration of NREM bouts was reduced 
only for Cre expressing control animals during the light phase (Figure 2.3D, 
F(4,86)=4.61, p=0.0020). The number of REM bouts was similar in all 3 groups (Figure 
2.3E, F(4,86)=2.5, p=0.05) and REM bout duration was reduced in FB CREB cKO during 
the light phase (Figure 2.3F, F(4,86)=5.55, p=0.0005). Taken together, these results 
suggest that CREB is required in the forebrain to sustain wakefulness.  
 
Deletion of CREB in the forebrain does not increase sleep homeostasis. Following 
the baseline day, animals were sleep deprived for 6 hours using gentle handling (Graves 
et al., 2003a; Graves et al., 2003b; Vecsey et al., 2009) starting at lights on and mice 
were allowed to recover for the subsequent 18 hours. FB CREB cKO animals showed 
similar total sleep rebound following sleep deprivation when compared to wild-type 
littermates (Figure 2.4A, F(8,9)=1.81, p=0.1966). NREM sleep (Figure 2.4B, F(8,9)=1.67, 
p=0.2310) and REM sleep (Figure 2.4C, F(8,9)=0.55, p=0.7973) also increased similarly 
in both groups during the recovery period (ZT 6-24). Slow wave activity (SWA), the 
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power in the delta (0.5-4Hz) frequency range during NREM sleep is a marker of sleep 
pressure and sleep intensity (Borbely et al., 1981; Borbely, 1982; Franken et al., 2001). 
SWA was normalized to the last 4 hours of the light phase during the baseline period for 
each animal (Franken et al., 2001; Halassa et al., 2009; Hasan et al., 2010). During the 
baseline period, SWA was highest at lights on and decreased over the course of the light 
phase (Figure 2.4D, time: F(3,54)=48.78, p<0.001). FB CREB cKO showed reduced 
SWA during the baseline day (time by genotype interaction: F(3,54)=4.46, p=0.0251). 
Following sleep deprivation, SWA was highest when the animals were allowed to sleep 
(ZT 6) and decreased during recovery sleep (Figure 2.4E, time: F(3,54)=134.38, 
p<0.0001). SWA was lower for FB CREB cKO (time by genotype interaction: 
F(3,54)=9.62, p=0.0002). These results indicate that, in forebrain neurons, CREB is not 
directly involved in the accumulation of sleep pressure and that CREB does not serve a 
restorative function during sleep.  
 
Deletion of CREB from forebrain neurons does not change EEG spectral content. 
We examined EEG spectral content using fast Fourier transform (FFT) of wake (Figure 
2.5A and B), NREM (Figure 2.5C and D) and REM sleep (Figure 2.5 E and F). In 
particular, we quantified power in the theta (6-10Hz) range during wakefulness, a marker 
of arousal as well as power in the delta range during NREM sleep, an indicator of sleep 
pressure. We found no difference in absolute theta power during wake (Figure 2.5G, 
F(2,42)=0.58, p=0.5646) or REM sleep (F(2,42)=0.79, p=0.4596). Delta power during 
NREM was also similar in all 3 groups (F(2,42)=0.69, p=0.5063). Because electrode 
placement can impact absolute power density, we also normalized each of these values 
to the overall average power for each animal. This normalization had no effect on theta 
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power during wake (Figure 2.5H, F(2,42)=2.39, p=0.1037) or delta power (F(2,42)=0.05, 
p=0.9510). Theta power during REM sleep was lower in Cre expressing controls 
compared to wild-type (F(2,42)=7.44, p=0.0017). A separate cohort of animals was used 
to examine circadian activity patterns in FB CREB cKO (n=6) and control (n=8) animals. 
Mice showed rhythmic activity patterns under 12h-12h light/dark conditions and under 
constant darkness. Deletion of CREB did not affect the period (control Tau=23.54±0.04; 
cKO Tau=23.64±0.08; p=0.202).  
 
CREB is not required in the LC to sustain wakefulness. In the next set of 
experiments, we investigated whether LC CREB signaling is required to sustain 
wakefulness in the LC, a brain area known to be critically involved in arousal and 
vigilance. We used the DBH promoter (Parlato et al., 2010) to confer deletion of CREB 
to noradrenergic neurons (LC CREB cKO, Figure 2.6A). LC CREB cKO mice showed 
reduced expression of CREB in neurons that were positive for tyrosine hydroxylase (TH) 
in the LC (Figure 2.6B, C and D, 86% reduction, p=1.19 x 10-5). LC CREB cKO mice 
showed similar levels of wake compared to wild-type littermates over 24 hours 
(p=0.4930) and during the light and dark phase (Figure 2.7A, F(2,14)=0.25, p=0.7803). 
NREM levels were also similar for both groups over 24 hours (p=0.4397) and during the 
light and dark phase (Figure 2.7B, F(2,14)=0.31, p=0.7383). REM sleep was also 
unchanged by deletion of CREB in LC neurons (Figure 2.7C, 24 hours, p=0.9837, 
light/dark F(2,14)=0.01, p=0.9950). LC CREB cKO showed similar levels of wake, NREM 
and REM sleep at each 3 hour time point across the light/dark cycle (wake: Figure 2.7D 
F(8,8)=1.30, p=0.3602, NREM: Figure 2.7E, F(8,8)=1.68, p=0.2386, REM: Figure 2.7F, 
F(8,8)=0.43, p=0.8702). Deletion of CREB from LC did not affect the number of bouts for 
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wake (Figure 2.8A, F(2,14)=0.42, p=0.6646), NREM (F(2,14)=0.29, p=07554) and REM 
sleep (F(2,14)=0.42, p=0.6630). The average duration for wake, NREM and REM sleep 
was similar in LC CREB cKO compared to wild-type littermates (Figure 2.8B, wake:  
F(2,14)=0.20, p=0.8208, NREM: F(2,14)=0.08, p=0.9211, REM: F(2,14)=1.23, 
p=0.3255). These results indicate that CREB is not required in the LC to promote 
wakefulness.  
 
Discussion 
The goal of this study was to identify where in the brain CREB is important for the 
induction and maintenance of wakefulness. The LC is a critical component of the arousal 
system and activity in noradrenergic neurons can desynchronize cortical EEG and 
produce arousal (Aston-Jones and Bloom, 1981; Berridge and Foote, 1991; Berridge et 
al., 1996; Berridge and Foote, 1996). Wake promoting regions share the cerebral cortex 
as a common output and cortical activity ultimately dictates behavioral state (Saper, 
2006; Datta and Maclean, 2007). We used conditional knock out approaches to 
separately test the role of CREB in these two components of the neural-circuitry known 
to control wakefulness.  
 
Our results reveal that CREB is required in forebrain neurons but not in the LC to sustain 
wakefulness. The reductions in wake that we observed in FB CREB cKO mice were due 
to the inability of these animals to sustain normal periods of wakefulness. Interestingly, 
CREB deficiency only destabilized wakefulness, sparing NREM and REM sleep 
architecture. The number of NREM sleep episodes increased, while the average 
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duration of NREM bouts was unchanged in the CREB mutants. Taken together, these 
results indicate that CREB is critical in forebrain neurons to sustain extended periods of 
wakefulness.  
 
 We used sleep deprivation experiments to test the possibility that reduced and 
fragmented wakefulness resulted from increased sleep pressure. Chronic heightened 
sleep pressure is characterized by enhanced sleep homeostatic responses as shown in 
chronic sleep restriction experiments (Leemburg et al., 2010) or in animal models with 
genetic manipulations resulting in increased sleep homeostasis (Naylor et al., 2000; 
Hendricks et al., 2001; Frank et al., 2002). In contrast, FB CREB cKO mice showed 
normal amounts of sleep rebound following brief sleep deprivation. Furthermore, the 
marker of sleep pressure SWA was reduced basally and after sleep loss in FB CREB 
cKO animals. One possibility is that conditional CREB mutant mice did not reach the 
same levels of sleep pressure as control animals due to the increased opportunity to 
discharge SWA during the active period. Interestingly, SWA for FB CREB cKO animals 
following enforced wakefulness are similar to SWA levels in control animals at lights on 
during the baseline day. These findings are consistent with the hypothesis that reduced 
SWA in CREB mutant mice stems from the inability to sustain wake during the active 
period. Hence, our findings indicate that CREB is not directly involved in sleep 
homeostasis and that CREB does not serve a restorative function during sleep. 
Additionally, animals lacking CREB in forebrain neurons were unable to sustain 
wakefulness but showed normal NREM and REM sleep architecture.  
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This phenotype is similar to that of animals constitutively lacking two isoforms of CREB 
(Graves et al., 2003b) and of animals lacking norepinephrine (Ouyang et al., 2004). One 
possibility is that LC efferents to cerebral cortex promote wake by activating the CREB 
signaling pathway. Consistent with this idea, increased pCREB in the cortex during 
wakefulness requires LC inputs (Cirelli et al., 1996). Beta adrenergic receptors are 
coupled to Gs and increase cAMP/PKA activity. Thus, increased cortical norepinephrine 
during wakefulness could lead to increase pCREB via beta adrenergic signaling. 
Consistent with this hypothesis, beta adrenergic agonist infusions into the basal 
forebrain increase wakefulness and arousal (Berridge and Foote, 1996). The peptide 
hypocretin/orexin is also thought to play a crucial role in the maintenance of 
wakefulness(Saper, 2006; Adamantidis et al., 2007; Saper et al., 2011) and loss of 
orexin signaling causes narcolepsy (Chemelli et al., 1999; Hara et al., 2001). 
Interestingly, orexin selectively excites a subpopulation of neurons in the deep layer of 
cortex that express the Gq coupled orexin-2 receptor (Bayer et al., 2004). Activation of 
these cells could also lead to increased pCREB via intracellular calcium release. These 
neurons also send broad projections to other cortical layers and their activation in turn 
could result in broad cortical activity.  
 
Consistent with previous reports, we found that deletion of CREB in the forebrain was 
accompanied by compensatory increased expression of cAMP response element 
modulator (CREM) (Hummler et al., 1994; Blendy et al., 1996; Rudolph et al., 1998; 
Mantamadiotis et al., 2002; Parlato et al., 2006; Parlato et al., 2010). CREM is nearly 
undetectable in the brain under normal conditions and this marked compensatory 
increase has been shown to partly restore CREB function (Mantamadiotis et al., 2002). 
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We were still able to detect changes in expression of CREB target genes Nr4a2 and 
Gadd45b. Interestingly, activity-dependent expression of these transcripts requires 
CREB activity in the hippocampus and striatum (Lemberger et al., 2008). Further studies 
are needed to determine whether these changes in gene expression are functionally 
relevant to the maintenance of wakefulness.  This work suggests that the arousal system 
efferents to the forebrain promote wakefulness via activation of CREB signaling. Further 
studies are needed to refine where in the forebrain CREB is required for the 
maintenance of wakefulness and which effector genes mediate arousal in these cells.  
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Figure Legends 
 
Figure 2.1. Forebrain CREB cKO animals show reduced CREB expression in 
cortex. 
A. Forebrain CREB cKO animals were generated using the cre/lox system. B. CREB 
protein levels were quantified using optical density (shown in arbitrary units) in parietal 
cortex of FB CREB cKO and wild-type littermates. * p<0.05. C and D. 
Immunohistochemical stains using anti-CREB antibody (brown nuclei) of cortex for wild-
type (C) and FB CREB cKO (D) mice. E and F. Sections from wild-type (E) and FB 
CREB cKO (F) cortex tissue were imaged using fluorescent microscopy for CREB 
(green) and propridium iodide (red). 
 
Figure 2.2. Deletion of CREB in forebrain neurons reduces wakefulness. Total time 
spent (min) in wake (A), NREM (B) or REM (C) sleep over 24 hours and during the light 
and dark phase. Percent time in wake (D), NREM (E) and REM sleep (F) across 24 h 
baseline period shown in 3 hour windows. Zeitgeber time (ZT) is represented on the x 
axis. Lights come on at ZT 0. Black line represents the dark period. ‡ compares cre-only 
to WT (p<0.05), * compares cKO to WT (p< 0.05).  
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Figure 2.3. FB CREB cKO mice are unable to sustain wakefulness. 
Number of bouts and average bout duration for wake (A and B, respectively), NREM (C 
and D) and REM sleep (E and F) during the light and dark phase. Mean ± s.e.m.  ‡ 
compares cre-only to WT (p<0.05), * compares cKO to WT (p< 0.05).  
 
Figure 2.4. Forebrain deletion of CREB does not increase sleep homeostasis. 
Animals were sleep deprived using gentle handling for 6 hours (ZT 0-6). Shown is 
absolute change in total sleep (A), NREM (B) and REM sleep time (C) between the 
recovery and baseline periods. Grey bar represents the SD period and black line 
represents the dark period. D. SWA during baseline light period. E. SWA (expressed as 
% of baseline) during recovery following 6 hours SD. Mean ± s.e.m., * p< 0.05. 
 
Figure 2.5. Deletion of CREB in forebrain does not alter EEG spectral content.  
EEG spectra were computed using FFT over 24 hours. Absolute and normalized power 
is shown for wake (A & B, respectively), NREM (C & D) and REM (E &F) sleep. G. 
Absolute Theta (6-10Hz) power during wake and REM sleep and NREM Delta (0.5-4Hz) 
power are shown for FB CREB cKO and control animals. H. Normalized Theta (6-10Hz) 
power during wake and REM sleep and NREM Delta (0.5-4Hz) power are shown for FB 
CREB cKO and control animals. Mean ± s.e.m., ‡ compares cre-only to WT (p<0.05), * 
compares cKO to WT (p< 0.05).  
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Figure 2.6. LC CREB cKO show reduced CREB expression in LC neurons.  
A. We used the cre/lox system to restrict deletion of CREB to noradrenergic neurons. B. 
Percentage of noradrenergic (TH positive) neurons also labeled for CREB is reduced in 
DBH CREB cKO animals. Mean ± s.e.m. * indicates p<0.05. C and D. Photomicrograph 
of LC sections stained using an anti-TH antibody (brown cells) and anti-CREB antibody 
(blue nuclei) for wild-type (C) and mutant (D) mice.  
 
Figure 2.7. LC CREB cKO animals show normal levels of sleep/wake.  
Total time spent (min) in wake (A), NREM (B) or REM (C) sleep over 24 hours and 
during the light and dark phase. Percent time in wake (D), NREM (E) and REM sleep (F) 
across 24 h baseline period shown in 3 hour windows. Zeitgeber time (ZT) is 
represented on the x axis. Lights come on at ZT 0. Black line represents the dark period. 
Mean ± s.e.m. 
 
Figure 2.8. Deletion of CREB in LC does not disrupt sleep/wake architecture. 
Number of bouts (A) and average bout duration for wake (B) for wake, NREM and REM 
sleep. Mean ± s.e.m.  
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Tables 
 
Table 2.1. FB CREB cKO mice show reduced expression of CREB target genes in 
the cortex during the active phase. 
 
 
 
Tissue from cortex was collected at ZT 16 from FB CREB cKO and control mice (n=6). 
Gene expression was measured using qPCR. Transcripts changed by deletion of CREB 
are shown in bold. Mean ± s.e.m.  
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Chapter 3. Aging in Mice Reduces the Ability to Sustain 
Sleep/Wake States 
Abstract 
Study Objective: To determine the effects of aging on sleep/wake patterns in C57BL/6 
mice using a novel statistical approach.  
Measurements and Results: We used EEG/EMG recordings to quantify wake, non-
rapid eye movement (NREM) and rapid-eye movement (REM) sleep. Aged animals 
showed decreased wake during the active (dark) period and decreased REM sleep 
during the rest (light) period. We used both conventional measures (i.e., bout number 
and bout duration) and a novel statistical approach to examine the micro-architecture of 
sleep and wake. The short (spike) and long (slab) components of the spike-and-slab 
mixture model captures the distribution of bouts for each behavioral state in mice. Using 
this novel analytical approach, we found that aged animals are less able to sustain long 
episodes wakefulness or NREM sleep. Spectral analysis of EEG recordings revealed 
that aging decreases low frequency slow wave activity, a marker of sleep quality that 
responds to the duration and nature of prior wakefulness. Aging also slowed theta peak 
frequency, a correlate of arousal and exploratory behavior.  
Conclusions: Aged mice are less able to sustain sleep/wake states. The spike-and-slab 
analytical approach enhanced our ability to detect age-related fragmentation of wake 
and NREM sleep compared to conventional measures. EEG spectral profiles of aged 
mice showed slowed theta peak frequency during wake and reduced low frequency 
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SWA during NREM sleep suggesting that fragmentation of wake and NREM lead to 
reductions in the quality of both of these states.  
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Introduction 
Life expectancy is on the rise worldwide. Within the US alone, it is estimated that 20% of 
the population will be over the age of 65 years by 2030 (US Census estimate, 2010). 
Normal aging produces sleep fragmentation and impairs the ability to sustain 
wakefulness in humans (Dijk et al., 1989; Ehlers and Kupfer, 1989; Bliwise, 1993; Prinz, 
1995; Landolt et al., 1996; Dijk et al., 2000), and rodents (Zepelin et al., 1972; 
Eleftheriou et al., 1975; Rosenberg et al., 1979; Ingram et al., 1982; Van Gool and 
Mirmiran, 1983; Welsh et al., 1986; Markowska et al., 1989; Stone et al., 1989; 
Mendelson and Bergmann, 1999; Colas et al., 2005; Hasan et al., 2010; Naidoo et al., 
2011). Aging has also been shown to impact the amplitude and timing of circadian 
biological rhythms (Ingram et al., 1982; Dijk et al., 2000; Weinert, 2000) and reduce the 
homeostatic response to sleep loss (Shiromani et al., 2000; Hasan et al., 2010). 
Previous studies suggest that alterations in neurotransmitter and receptor levels in brain 
regions that regulate sleep/wake underlie these age-induced disruptions in sleep. Levels 
of adenosine, a sleep promoting endogenous purine, are higher under baseline 
conditions and following sleep loss in aged rats (Murillo-Rodriguez et al., 2004; 
Mackiewicz et al., 2006), whereas adenosine A1 receptor binding is reduced with age 
(Meerlo et al., 2004). In addition, aged animals show lower extracellular levels of the 
wake promoting peptide hypocretin (orexin) and a reduction in the expression of 
hypocretin receptors (Terao et al., 2002; Desarnaud et al., 2004). Orexinergic and 
noradrenergic neurons in aged mice also show reduced activity during the active phase 
(Naidoo et al., 2011). These age-related disruptions in signaling may underlie the 
inability to maintain wakefulness and sleep, as well as the alterations of EEG spectral 
profile that accompany normal aging. These two hallmarks of aging have been well 
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characterized in humans (Dijk et al., 1989; Bliwise, 1993; Prinz, 1995; Landolt et al., 
1996) and rats (Zepelin et al., 1972; Rosenberg et al., 1979; Van Gool and Mirmiran, 
1983; Markowska et al., 1989; Stone et al., 1989; Mendelson and Bergmann, 1999). 
Interestingly, few studies have investigated the effects of normal aging on sleep in mice  
(Eleftheriou et al., 1975; Welsh et al., 1986; Hasan et al., 2010; Naidoo et al., 2011) and 
only one recent report (Hasan et al., 2010) examined the impact of aging on the spectral 
profile of the EEG during sleep. To address changes in sleep with aging in mice to lay 
the groundwork for future genetic studies, we studied differences in EEG spectral profile 
and sleep architecture of young and aged C57BL/6 mice, one of the most commonly 
used stains of mice in genetic and pharmacological studies. The unique architecture of 
rodent sleep is characterized by the uneven distribution of short and long bouts in each 
behavioral state (Lo et al., 2004; Blumberg et al., 2005; Joho et al., 2006; Behn et al., 
2007; Blumberg et al., 2007; Diniz Behn et al., 2008; Simasko and Mukherjee, 2009), 
rendering average bout duration a poor descriptor of sleep/wake structure. Here, we 
used a novel statistical approach (McShane et al., 2010) which faithfully models both 
components of each behavioral state and permits the analysis of short and long bouts 
simultaneously. We hypothesized that aging impairs the ability to sustain the longer 
bouts of sleep and wake.  
 
Methods 
Animals and Surgery: 8 young (2-4 months) and 12 old (22-24 months) male 
C57BL/6NIA mice were obtained from the National Institute of Aging mouse colony. 
Animals were maintained on a 12 hour light/12 hour dark cycle with lights on (ZT 0) at 
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7:00 am. Food and water were available ad libitum. All animal care and experiments 
were approved by the Institutional Animal Care and Use Committee of the University of 
Pennsylvania and conducted in accordance with the National Institute of Health 
guidelines. Animals were implanted with EEG and EMG electrodes under isoflurane 
anesthesia. Electrodes were held in place with dental cement (Ketac, 3M, St Paul, MN). 
Electrodes consisted of Teflon coated wires (Cooner wires, Chatsworth, CA) soldered to 
gold socket contacts (Plastics One, Roanoke, VA) and pushed into a 6-pin plastic plug 
(363 plug, Plastics One). The contacts were cemented to the plug using dental cement. 
Animals were connected to amplifiers using light-weight cables (363, Plastics One) 
attached to a rotating commutator (SLC6, Plastics One). All recordings were obtained 
using a parietal electrode (ML ±1.5mm, AP -4mm from bregma) referenced to an 
electrode over the cerebellum (1.5 mm posterior of lambda). Mice were allowed to 
recover from surgery for a minimum of 2 weeks. During the second week of recovery, 
mice were acclimated to the cables and to the recording chambers.  
 
EEG recordings and analysis: EEG/EMG signals were sampled at 256 Hertz (Hz) and 
filtered at 0.5-30Hz and 1-100Hz, respectively with 12A5 amplifiers (Astro-Med, West 
Warwick, RI). Data acquisition and visual scoring was performed using SleepSign 
software (Kissei Comtec, INC, Japan). EEG/EMG recordings were scored in 4 second 
epochs as wake, NREM, or REM by a trained experimenter blind to age. Epochs 
containing movement artifacts were included in the state totals and architecture analysis, 
but excluded from subsequent spectral analysis. Spectral analysis was performed using 
a fast Fourier transform (FFT; 0.5-20Hz, 0.125Hz resolution). Wake EEG spectra were 
computed during the dark phase, when wakefulness prevails. NREM and REM EEG 
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spectra were calculated during the light phase, when mice are mostly asleep. NREM 
slow wave activity (SWA) from ZT 0-8 was computed in 4 x 2-hour bins and SWA was 
normalized to the last 4 hours of the light phase for each animal as previously described 
(Franken et al., 2001).  
 
Statistics: Student’s t-tests were used to compare wake, NREM and REM sleep levels 
averaged over 24 hours. Multivariate analysis of variance (MANOVA) was used on the 
proportion of time spent in each state during the light phase, the dark phase and during 
the 8 x 3-hour bins across 24 hours, followed by Tukey studentized range tests to 
compare the 2 age groups. The same procedure was applied to the number of bouts and 
the average bout duration to compare age groups. In addition, a novel spike-and-slab 
statistical model was used to examine sleep/wake microstructure. This mixture model, 
where short bouts are represented by the spike and long bouts are captured by the slab 
component was previously described in detail (McShane et al., 2010). Rather than 
modeling the sequence of sleep states directly, this approach models the sequence of 
unique states and their duration.  The unique states do not form a Markov chain, 
because the durations are not exponentially distributed. A Kruskal-Wallis test revealed 
that the duration of a bout is dependent upon the previous behavioral state (Table 1). 
Thus, each state was fit using two separate models. Bout durations have been 
traditionally modeled as gamma-distributed random variables. However, we found that 
gamma assigns too little probability to short (spike) bouts and too much probability to 
very long bouts (slabs, see Figure 3.3). The spike and slab model consists of a mixture 
of a gamma distribution and point masses at k bouts for k=1, 2, …, 10. Standard model 
selection methods including the Bayesian Information Criterion (BIC) and nonparametric 
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Q-Q plots were used to determine whether the spike-and-slab formulation constitutes a 
better fit than a single distribution. These tests revealed that the multi-parameter mixture 
model is necessary and that the spike-and-slab distribution provides a far better fit than 
any single two-parameter gamma distribution, as we previously reported in C57BL/6 
mice (McShane et al., 2010).The spike and slab probability model was used to generate 
a set of 12 descriptive summary statistics that can be further distilled into three key 
parameters: 1) n, the number of bouts of the behavioral state, conditional on the 
previous state 2) π, the proportion of spikes (short bouts) 3) μ, the average duration of 
the slabs (long bouts).  
Tukey studentized range tests were used to analyze raw EEG spectra for wake, NREM 
and REM sleep. Student’s t-tests were used to analyze theta peak frequency for wake 
and REM EEG spectra. NREM SWA during the 4 x 2-hour bins was analyzed using 
repeated measures ANOVA followed by Tukey studentized range tests. Pearson’s 
correlation was used to examine the relationship between time awake during the dark 
phase and SWA during the first two hours of the subsequent light period.  
 
Results 
Aged mice have decreased wakefulness during the active period.   
We used EEG/EMG recordings from young (2-4 months) and old (22-24 months) mice to 
quantify wake, NREM and REM sleep. Aged animals showed decreased wakefulness 
over 24 hours compared to young (Satterthwaite t-test, p=0.039, Figure 3.1A). In 
comparison to young animals, aged mice spend more time awake during the light period 
and less time awake during the dark phase, when mice are typically active 
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(F(2,17)=10.84, p<0.001, Figure 3.1A). We also found that age affects the percentage of 
time spent awake across the light/dark cycle (F(8,11)=7.4, p=0.0017, Figure 3.1B). We 
used Tukey studentized range tests to examine the effect of age at 8 x 3 hour bins 
across the 24-hour period (Figure 3.1B). These tests revealed that aged mice have more 
wakefulness at the end of the light period and show decreased wake during most of the 
dark phase (Figure 3.1B). Decreased wakefulness in aged mice over 24 hours was 
accompanied by increased NREM sleep (t-test, p=0.031). This increase was most 
obvious during the dark phase (F(2,17)=12.91, p<0.001, Figure 3.1C). Indeed, aged 
mice showed increased NREM sleep at 3 of the 4 time points during the dark period 
(F(8,11)=7.3, p=0.002, Figure 3.1D). REM sleep was overall unchanged when averaged 
over 24 hours (t-test, p=0.17, Figure 3.1E). However, aged animals showed decreased 
REM sleep during the light phase (F(2,17)=6.51, p=0.008, Figure 3.1E). When analyzed 
in 3 hour bins, aged animals showed decreased REM sleep during most of the light 
phase and increased REM sleep during one time point of the dark phase (F(8,11)=4.3, 
p=0.014, Figure 3.1F).  
 
Aged mice have reduced ability to sustain sleep/wake states.  
Next, we examined sleep and wake architecture in young and aged mice using 
conventional measures (i.e., number of bouts and average bout duration) for each state. 
Aged mice had more bouts of wakefulness during the dark period compared to young 
mice (F(2,17)=14.90, p=0.0002) and the average duration of wake bouts was shorter in 
old mice during the dark phase (F(2,17)=18.07, p<0.0001, Figure 3.2A). Similarly, the 
number of NREM bouts was higher in old mice during the dark phase (F(2,17)=12.31, 
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p=0.0005) and the average NREM bout duration was lower in aged animals 
(F(2,17)=9.7, p=0.0015, Figure 3.2B). The number of REM bouts was not affected by 
age (F(2,17)=2.46, p=0.1151) and neither was the average duration of REM bouts 
(F(2,17)= 2.14 , p=0.1484, Figure 3.2C). We also used a new spike-and-slab mixture 
model to compare sleep/wake microstructure in young and aged animals (McShane et 
al.). Typically, bout durations have been modeled as gamma-distributed random 
variables. However, we found that gamma assigns too little probability to short bouts and 
too much probability to very long bouts (Figure 3.3). The short (spike) and long (slab) 
components of this model permit an improved fit of the distribution of bout durations in 
mice (Figure 3.3). This was confirmed using BIC and Q-Q plots-based analyses. In 
addition, we found that the duration of a bout in a given state is dependent upon the 
previous state of the animals (Table 3.1). Therefore, each state was analyzed using two 
models. For example, wake state was analyzed separately for wake bouts that were 
preceded by NREM bouts and wake bouts that were preceded by REM sleep. The 
number of NREM to wake episodes and wake to NREM bouts was higher in aged mice 
(p=9.35 x 10-6 and p=6.43 x 10-5, respectively, Figure 3.4A). In addition, the average 
duration of the slab was shorter for both wake and NREM sleep in aged mice (p=1.53 x 
10-5 for NREM to wake and p= 1.67 x 10-3 for wake to NREM, Figure 3.4B). Thus, the 
major difference between young and old mice is in the ability of old mice to sustain long 
bouts of NREM sleep and wakefulness. The architecture of sleep/wake was only 
disrupted in aged mice when animals were transitioning between wake and NREM 
sleep. However, aging did not disrupt the architecture of REM sleep during the dark 
phase (Table 3.2) or during the light phase (Table 3.3).   
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Aged mice show reduced slow wave activity (SWA) and slower theta peak 
frequency (TPF)  
We used fast Fourier transform (FFT) of EEG recordings to examine the EEG spectral 
profiles during each behavioral state for both age groups. Wake EEG spectra from both 
young and old animals showed a peak in the theta frequency range but aged mice 
showed reduced power in the theta range at frequencies between 8.5-9.625Hz (Tukey 
Studentized range t-test, Figure 3.5A). Interestingly, age did not affect NREM sleep 
spectra, which showed a characteristic peak in the delta (0.5-4Hz) frequency range in 
both young and aged animals (Figure 3.5B).  Aged mice showed higher power for a 
small range of frequencies of the REM sleep spectra (2.375-2.625, Figure 3.5C). Theta 
peak frequency (TPF) was determined by recording the frequency at which absolute 
power was highest in the theta range (6-10Hz). Aging slowed TPF by about 1.5 Hz from 
7.5±0.39Hz to 6.03±0.02Hz in the wake EEG spectra (Satterthwaite t-test, p=0.0072, 
Figure 3.5D). Similarly, TPF was lower by about 0.34Hz in aged mice (6.63±0.05Hz) 
compared to young (6.97±0.09Hz) in the REM spectra (t-test, p = 0.0026, Figure 3.5D). 
The height of the peak in the theta range was not changed by aging during wake or REM 
sleep. Slow wave activity (SWA), the spectral power of the EEG in the 0.5-4 Hz range 
during NREM sleep is the best characterized marker of sleep intensity and changes in 
response to sleep loss (Borbely et al., 1981; Borbely, 1982). Repeated measures 
ANOVA revealed that SWA (0.5-4Hz) decreased over the course of the light phase 
(F(3,54)=58.87, p<0.0001, Figure 3.5E), and that SWA (<4Hz) was not different between 
young and aged mice (F(1,18)=0.54, p=0.47). These results suggest that sleep pressure 
is discharged similarly during the rest period in young and aged mice. In addition, the 
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time spent awake during the dark phase was not correlated with SWA (<4Hz) during the 
first two hours of the subsequent light phase (Pearson’s, R2=0.14, p=0.54). SWA in 
lower frequencies (0.5-1.5 Hz) is sensitive to changes in arousal and exploratory 
behavior during the preceding active period (Cirelli et al., 2005; Qu et al., 2010). Thus, 
changes in low frequency SWA (0.5-1.5Hz) is indicative of altered vigilance and 
exploration during wakefulness. We found that low frequency SWA (0.5-1.5Hz) 
decreases over the course of the light phase (F(3,54)=20.38, p<0.0001) and that low 
frequency SWA is lower during the first two hours of the light phase in aged mice 
compared to young animals (F(3,54)=6.57, p=0.0007, Figure 3.5F). Consistent with this 
finding, time awake during the active period was positively correlated with low frequency 
SWA during the first two hours of the subsequent light phase (Pearson’s, R2=0.49, 
p=0.03), suggesting that the decrease in low frequency SWA is due in part to reduced 
wake during the active period. One possibility is that aged animals have less opportunity 
for exploration during the dark phase, which leads to reduced low frequency SWA during 
the early part of the light phase.  
 
Discussion 
We confirmed and extended previous studies examining age-associated changes in 
sleep/wake patterns with disturbances of sleep and wakefulness in aged mice. Studies 
in the past 50 years have mapped the complex neural-circuitry that controls wakefulness 
and sleep. The consensus based on these electrophysiological, genetic and lesion 
experiments is that interactions between wake-producing and sleep-promoting networks 
control transitions from one state to the next, while separate components of these 
 
 
55
networks stabilize each state (Parmentier et al., 2002; Mochizuki et al., 2004; Lu et al., 
2006; Takahashi et al., 2006, 2009; Qiu et al., 2010; Qu et al., 2010; Takahashi et al., 
2010; Saper et al., 2011). Consistent with this idea, behavioral states can be further 
classified into short and long bouts in rodents (Lo et al., 2004; Blumberg et al., 2005; 
Joho et al., 2006; Blumberg et al., 2007; Diniz Behn et al., 2008; Simasko and 
Mukherjee, 2009). Historically, the conventional measures that are used to characterize 
behavioral structure measure each of these components separately by computing the 
number of transitions from one state to the next, the number of bouts for each state and 
the average bout duration for wake, NREM and REM sleep (Parmentier et al., 2002; 
Ouyang et al., 2004; Diniz Behn et al., 2010; Qu et al., 2010).  However, these standard 
metrics are correlated with one another and do not give independent views of each 
behavioral state. Our improved understanding of the biological mechanisms governing 
sleep/wake structure necessitated the creation of new models that better reflect and 
capture the complexity of these processes. Some recent models of sleep/wake 
dynamics have used a mixture of distributions to account for the uneven distribution of 
bout lengths (Behn et al., 2007; Simasko and Mukherjee, 2009; Chu-Shore et al., 2010; 
McShane et al., 2010). Our approach builds upon this literature, using a mixture of 
distributions to simultaneously model short and long processes for each state transition. 
Thus, this novel spike and slab formulation permits the quantification of all unique states, 
number of bouts and bout duration for each sub-stage of wake, NREM and REM sleep. 
We believe this model best reflects the complexity of sleep/wake dynamics in mice. This 
analytical approach was previously used to confirm that sleep/wake architecture is under 
genetic control (Franken et al., 1999; McShane et al., 2010). The current study shows for 
the first time that spike-and-slab analysis can also be used to detect changes in 
sleep/wake microstructure that accompany aging in mice. Our results suggest that aging 
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disrupts the ability to sustain long bouts of wakefulness and NREM sleep without 
affecting REM sleep architecture. We found that transitions from wake to NREM and 
NREM to wake were uniquely altered by aging. These transitions are regulated by a 
defined population of neurons, composed of two mutually inhibitory networks. The wake-
producing component includes the locus Coereleus (LC), Tuberomamillary nucleus 
(TMN) and the ventrolateral periaqueductal gray (vPAG) (Takahashi et al., 2006, 2009; 
Takahashi et al., 2010; Saper et al., 2011). Opposing these regions, the ventro-lateral 
preoptic area (VLPO) promotes sleep (Lu et al., 2006) and inhibits the LC, TMN and 
vPAG. Firing of noradrenergic cells of the LC precedes the onset of wakefulness out of 
NREM sleep, but not out of REM sleep (Takahashi et al., 2010), suggesting that these 
cells are critical to switching from NREM sleep to wake. Furthermore, LC neurons show 
highest discharge rates during high vigilance (Takahashi et al., 2010), indicating a dual 
role for both the induction and maintenance of wakefulness. Interestingly, aged animals 
show decreased staining in noradrenergic neurons during the dark phase  for the 
immediate early gene FOS, which has been used as a proxy for neuronal activity 
(Naidoo et al., 2011). Reduced LC activity may contribute to the reductions in 
wakefulness and the inability to sustain wake that we observed. In addition, the (VLPO) 
shrinks with age (Gaus et al., 2002) and the number of VLPO cells is decreased in aged 
animals (Senut et al., 1989). These neurons are particularly important for REM and 
NREM sleep (Lu et al., 2000; Lu et al., 2006). Alterations in the activity patterns and 
neurotransmitter release from LC and VLPO may contribute to more transitions between 
these two states and reduce the inability of aged mice to maintain wakefulness and 
NREM sleep. Reduced REM sleep may be caused by reduced activity in “REM-on cells” 
of the VLPO during the light phase. Conversely, reduced activity in the LC and 
orexinergic cells of the hypothalamus (Naidoo et al., 2011) in aged mice may lead to 
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increased NREM sleep during the light phase. In light of recent findings regarding the 
complex nature of the VLPO, further anatomical studies of the VLPO in aged animals 
would be needed to address these questions. In addition, VLPO lesions do not 
completely abolish sleep (Lu et al., 2000), suggesting that other unidentified brain 
regions also contribute to sleep.  
 
Theta activity during wakefulness is correlative of arousal, exploratory behavior, and 
spatial navigation (Winson, 1978; Raghavachari et al., 2001; Wyble et al., 2004; Kunec 
et al., 2005) and we found that aging slowed the peak in the theta component of the 
wake EEG spectra. Intriguingly, spatial navigation and exploratory behavior are also 
impaired by aging (Barnes, 1979; Gage et al., 1984; Markowska et al., 1989), which 
raises the possibility of a connection between the disruptions of sleep/wake and the 
cognitive impairments that occur with normal aging. We also measured SWA at low 
frequencies (0.5-1.5Hz) because this frequency range is particularly sensitive to 
changes in exploratory behavior and reductions in arousal (Cirelli et al., 2005; Qu et al., 
2010). Animals with lesions to the LC show reduced exploratory behavior and decreased 
low frequency SWA during the early part of the light phase (Cirelli et al., 2005). This 
manipulation also decreases markers of synaptic potentiation in the cortex during 
wakefulness, suggesting that low frequency SWA is a marker of synaptic plasticity 
during wakefulness. We found that decreased low frequency SWA (0.5-1.5 Hz) in aged 
mice in the first two hours of the light phase is partly due to reduced wake time during 
the preceding dark period. Because the correlation between wake time and SWA is fairly 
weak, other factors are likely to contribute to lower SWA in aged mice. Alterations in the 
continuity of wakefulness and reduced exploratory behavior in aged mice may in turn 
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lead to reduced synaptic plasticity in the cerebral cortex during the active period. 
Consistent with this hypothesis, theta activity and exploratory behavior during wake can 
affect subsequent SWA during sleep (Huber et al., 2007), suggesting that slower TPF 
and lower SWA (<1.5Hz) in aged animals may be linked. Taken together, our results 
suggest that further studies examining the quality of wakefulness are needed to explore 
the possibility that alterations in sleep/wake patterns are related to age-related cognitive 
impairments. 
 
The age-related changes in sleep/wake patterns that we observed are specific to 
circadian time as previously reported (Welsh et al., 1986; Colas et al., 2005; Hasan et 
al., 2010), indicating that changes in circadian rhythms caused aging are linked to 
disruptions of sleep/wake states. Consistent with this hypothesis, the superchiasmatic 
nucleus (SCN), which drives circadian rhythm in mammals, is directly affected by aging. 
SCN cells show altered firing patterns or cease to fire rhythmically in aged mice (Nygard 
et al., 2005). In addition, the rhythm of clock gene expression in the SCN of aged mice 
shows reduced amplitude and rhythmic clock gene expression is either less stable or 
phase advanced in aged animals (Weinert et al., 2001). Therefore, lower SCN outputs 
during the dark phase may contribute to destabilization of wakefulness and NREM sleep.    
 
In conclusion, the spike-and-slab approach, which simultaneously models short and long 
processes for all state transitions, is useful for characterizing the underlying mechanisms 
controlling both short and long bouts of each behavioral state. The major effect of age is 
to limit the durations of sleep and wake that old mice can sustain during the active 
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period. This provides a window into future investigations to the mechanisms involved in 
the maintenance of wake and NREM sleep.  
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Figure Legends 
Figure 3.1. Aged mice show reduced wakefulness during dark phase and 
decreased REM sleep during light phase. A. Total time (min) spent awake for young 
and old mice over 24 hours (left) and during the light and dark period (right). B. Percent 
time spent awake shown in 8 x 3-hour bins across light/dark cycle. Solid line represents 
the dark period C. Aged mice show increased NREM sleep during the dark phase. Total 
time spent in NREM sleep over 24 hours (left) and during the light and dark period 
(right). D. Percent time spent in NREM in 3-hour bins. E. Old mice have decreased REM 
sleep during the rest period. Total time spent in REM sleep for young and old mice over 
24 hours (left) and during the light and dark period. F. Percent time spent in REM sleep 
shown in 3-hour bins across light/dark cycle. Mean ± standard error of the mean 
(s.e.m.), * p<0.05. 
 
Figure 3.2. Aging causes fragmentation of wake and NREM sleep. A. Number of 
bouts of wakefulness (left) and average wake bout duration (right) during the light and 
dark phase. Aged mice show more bouts of wakefulness of shorter average duration 
during the dark phase. B. Aged mice show fragmented NREM sleep during the dark 
phase. Number of NREM bouts (left) and average NREM bout duration (right) during the 
light and dark phase. C. Number of REM episodes (left) and average REM bout duration 
during the light and dark period. Mean ± s.e.m., * p<0.05. 
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Figure 3.3. Spike and Slab model shows improved fit over single distribution. 
Distribution of NREM to Wake bout durations are shown for young and old mice during 
the light (A) and dark period (B).  The solid line represents the density of the spike and 
slab model, and the dashed line represents the density of the traditional gamma model.  
The gamma model assigns too little probability to short bouts and too much probability to 
long bouts.  
 
Figure 3.4. Aged mice are unable to sustain long bouts of wakefulness and NREM 
sleep. A. Number of slabs (long bouts) during the dark phase for young and old mice 
transitioning from NREM to wake (left) and from wake to NREM (right). Aged mice show 
an increased number of slabs for both states. B. Average duration of slabs for mice 
transitioning from NREM to wake (left) and wake to NREM (right). The duration of the 
slabs for both transitions is reduced in aged animals. Mean ± s.e.m., ‡ p<0.00625 
(Bonferroni correction). 
 
Figure 3.5. Aging slows TPF and decreases SWA. A. Wake EEG spectra calculated 
during the dark period for young and old mice. Aged animals show lower power in the 
higher frequency range. B. EEG spectra for NREM sleep generated during the light 
period for young and aged mice. Aging did not profoundly affect NREM spectral profile. 
C. EEG spectra of REM sleep computed during the light phase for young and old mice. 
D. Theta peak frequency (TPF) for wake and REM EEG during the dark and light phase, 
respectively. TPF slowed with aging for both states. E. Slow wave activity (0.5-4Hz, 
SWA) of NREM sleep for young and old mice expressed relative to the last 4 hours of 
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the light period (=100%) for each animal. F. Low frequency (0.5-1.5) SWA of NREM 
sleep young and old mice expressed relative to the last 4 hours of the light period 
(=100%) for each animal. Mean ± s.e.m., gray bar and * indicate p<0.05. 
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Tables: 
 
Table 3.1. Bout duration in a given state is conditional on the previous state. 
 
Wake and NREM bout durations were subdivided according to the previous state. 
Shown are the medians (in 4 second epochs) for each group. Kruskal-Wallis tests were 
used to compare bout durations for young and old mice during the light and dark period. 
* indicates p-values that are significant after Bonferonni correction. 
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Table 3.2. Spike-and-slab analysis, dark period 
 
Transition Quantity Young Old p-value 
NREM to REM 
n 
μ 
π 
25.88 ± 9.06 
19.22 ± 4.20 
0.55 ± 0.16 
36.00 ± 16.10 
20.93 ± 7.52 
0.59 ± 0.23 
0.125 
0.569 
0.700 
 
NREM to Wake 
 
n 
μ 
π  
104.63 ± 25.06 
245.79 ± 48.58 
0.79 ± 0.085 
213.67 ± 46.01 ** 
137.39 ± 34.54 ** 
0.81 ± 0.04 
9.35x10-6 
1.53x10 -5 
0.574 
 
REM to Wake 
 
n 
μ 
π  
25.88 ± 8.86 
363.83 ± 363.224 
0.77 ± 0.07 
35.67 ± 16.12 
93.55 ± 52.70 
0.80 ± 0.08 
0.136 
0.019 
0.437 
 
Wake to NREM 
 
n 
μ 
π  
130.38 ± 31.86 
26.02 ± 5.07 
0.27 ± 0.09 
249.08 ± 59.11 ** 
18.89 ± 3.60 ** 
0.28 ± 0.16 
6.43x10-5 
1.67x10-3 
0.794 
 
Spike-and-slab analysis of each state during the dark period for young and old mice. n = 
number of slabs, μ = average duration of slabs (in epochs), π = probability that the 
animal is in a spike (short bout). Mean ± standard deviation. ** p<0.00625 (Bonferroni 
correction).  
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Table 3.3. Spike-and-slab analysis, light period 
Transition Quantity Young Old p-value 
NREM to REM 
n 
μ 
π 
84.00 ± 11.28 
21.74 ± 1.54 
0.45 ± 0.11 
77.00 ± 16.51 
22.14 ± 3.06 
0.54 ± 0.11 
0.311 
0.734 
0.074 
 
NREM to Wake 
 
n 
μ 
π  
205.38 ± 49.69 
90.64 ± 21.43 
0.89 ± 0.03 
224.67 ± 49.65 
84.91 ± 22.02 
0.83 ± 0.06 
0.406 
0.571 
0.025 
 
REM to Wake 
 
n 
μ 
π  
80.50 ± 10.39 
66.29 ± 41.66 
0.88 ± 0.05 
73.00 ± 16.73 
42.06 ± 17.29 
0.86 ± 0.10 
0.275 
0.086 
0.533 
 
Wake to NREM 
 
N 
μ 
π  
284.88 ± 53.42 
25.52 ± 4.28 
0.22 ± 0.09 
297.25 ± 58.10 
23.73 ± 4.85 
0.26 ± 0.12 
0.636 
0.409 
0.529 
 
REM to NREM 
 
n 
μ 
π  
4.125 ± 1.126 
12.346 ± 10.995 
0.250 ± 0.250 
4.167 ± 2.250 
16.584 ± 18.730 
0.310 ± 0.358 
0.962 
0.572 
0.690 
 
Spike-and-slab analysis of each state during the light period for young and old mice. 
n=number of slabs, μ = average duration of slabs (in epochs), π =probability that the 
animal is in a spike. Mean ± standard deviation. No differences were significant during 
the light period 
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Chapter 4. Aging impairs hippocampus-dependent long-
term memory for object location in mice 
Abstract 
The decline in cognitive function that accompanies normal aging has a negative 
impact on the quality of life of the elderly and their families. Studies in humans 
and rodents show that spatial navigation and other hippocampus-dependent 
functions are particularly vulnerable to the deleterious effects of aging. However, 
reduced motor activity and alterations in the stress response that accompany 
normal aging can hinder the ability to study certain cognitive behaviors in aged 
animals. In an attempt to circumvent these potential confounds, we used a 
hippocampus-dependent object-place recognition task to show that long-term 
spatial memory is impaired in aged mice. Aged animals performed similarly to 
young adult mice on an object recognition task that does not rely on hippocampal 
function. 
 
 
 
 
Chapter in press as:  
M.E. Wimmer, P. Hernandez, J. Blackwell, T. Abel, Aging impairs hippocampus-
dependent long-term for object location in mice, Neurobiology of Aging, Epub 2011. 
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Introduction  
Over the past 30 years, considerable effort has been devoted to the identification and 
characterization of the neurological and molecular pathways that underlie age-related 
cognitive impairments. Studies in humans and rodents show that the hippocampus is 
particularly vulnerable to the effects of aging (Davis et al., 1993; Bach et al., 1999; 
Gallagher et al., 2010), leading to impairments in episodic memory (Miller and 
O'Callaghan, 2005; Park and Reuter-Lorenz, 2009) and spatial navigation (Barnes, 
1979; Gage et al., 1984; Markowska et al., 1989). However, confounding factors such as 
changes in motor activity and in the response to stress that accompany normal aging 
can complicate the interpretation of studies using the Morris water maze and other 
spatial navigation tasks (Sparkman and Johnson, 2008). The present studies focus on 
object memory tasks, which are ideal to study both short- and long-term memory 
formation because learning occurs within a single session (Baker and Kim, 2002; de 
Lima et al., 2006; Oliveira et al., 2010). Furthermore, object-based tasks take advantage 
of the innate tendency of mice to explore novel items in their environment, while inflicting 
little stress on the animals (Save et al., 1992; Sharma et al., 2010), and the anatomical 
substrates underlying object memory are well characterized (Ennaceur and Aggleton, 
1997; Oliveira et al., 2010; Roozendaal et al., 2010).  
Methods 
Subjects  
Young (2-4 months-old) and old (22-24 months-old) male C57BL/6NIA mice provided by 
the National Institute of Aging were used in all experiments. Food and water were 
provided ad libitum. Lights were maintained on a 12-12 light/dark cycle, and all 
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experiments were performed in the light phase. Mice were singly housed a week before 
training. Animals were handled in the experimental room for 1 minute per day for 3 days 
prior to the first exposure to the training arena. All experiments were approved by the 
Institutional Animal Care and Use Committee of the University of Pennsylvania and 
conducted according to National Institutes of Health guidelines. 
Object location memory task 
Object location memory experiments were performed as described previously (Oliveira 
et al., 2010) with minor modifications. On the day of training, mice were placed in the 
training arena for a total of four 10-minute sessions with an inter-session interval of 3 
minutes during which mice were returned to their home cages. The first session 
consisted of a context habituation period without objects in the arena. During the next 
three sessions, mice were placed in the training arena with two distinct objects. The 
objects used were a glass bottle, and a metal tower (5’’H x 2’’W x 2’’L). The objects and 
the arenas were wiped with 70% ethanol before each session. Either 3 minutes or 24 
hours after training, mice were placed in the original training arena for 10 minutes with 
one object displaced to a new location (displaced object, DO), while the other object was 
not moved (non-displaced object, NDO). Exploration was recorded during training and 
testing on a digital camera for subsequent scoring of time spent exploring objects. 
Exploration of the objects was defined as the amount of time mice were oriented toward 
an object with its nose within 1 cm of it, and was scored by an experimenter blind to age.  
Object recognition memory task 
Object recognition memory experiments were performed in the same training arenas and 
using the same objects as previously described (Oliveira et al., 2010). Mice were pre-
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exposed to the training context for 10 minutes on 3 consecutive days prior to object 
training. 24 hours after the last context exposure, mice were placed in the training arena 
with two identical objects and allowed to explore for 10 minutes. Twenty-four hours after 
training, mice were placed in the original training arena for 10 minutes with one familiar 
object and one novel object in the same locations used during training. Exploration was 
measured and recorded as described above.  
Data analysis  
Percent preference in the object location experiment was calculated as time spent 
exploring the DO relative to the total time spent exploring both objects (i.e., preference = 
DO/(NDO+DO)). For object recognition experiments, percent preference was calculated 
as time spent exploring the novel object relative to the total time exploring both objects 
(i.e. novel/(familiar + novel)). 
Repeated measures ANOVAs (RM-ANOVA) were used to compare age groups, during 
training and retention test sessions for both tasks, with session as a within subject factor 
and age as a between subject factor. Tukey post-hoc tests were used in the event of a 
significant session x age interaction. p<0.05 was considered significant.  
Results 
We assessed hippocampal function and spatial memory formation in aged mice by using 
a hippocampus-dependent object place recognition task (Save et al., 1992; Mumby et 
al., 2002; Oliveira et al., 2010). Training consisted of three 10-minute exposures (3 
minute inter-trial interval) to an arena that contained two distinct objects (Fig. 4.1A). Both 
groups of animals spent an equal amount of time exploring what would ultimately be the 
DO and NDO (RM-ANOVA, F(2,74)=0.18, p=0.83) where exploration of the objects 
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gradually decreased over time (F(2,74)=33.98, p<0.001). Age had no effect on the time 
spent exploring the objects (F(1,18)=2.29, p=0.14) and total exploration times for 
sessions 1, 2 and 3 were 8.4 ± 1.0, 5.9 ± 1.3, 5.0 ± 0.6 seconds, for young mice, and 
11.7 ± 0.8, 6.9 ± 0.6, 5.3 ± 0.7 seconds, for aged mice. Twenty-four hours after the last 
session, young and old mice were re-introduced to the training arena with one of the two 
objects displaced to a new location. The relative preference for the DO was calculated 
as the percentage of object exploration time dedicated to this object. We compared the 
preference for the DO for each age group during the last training session to the 
preference during the 24 hour test. The preference for the DO increased during the test 
for young mice, whereas old animals did not show a preference for either object during 
either sessions (session x age interaction: F(1,18)=5.15, p=0.036).  Aged mice showed 
lower preference for the DO than young animals (post-hoc Tukey tests , p<0.05) only 
during the 24 hour retention test session, suggesting that aged mice have impaired 
spatial memory (Fig. 4.1 B). Next, we assessed short term memory, using the same 
training protocol in a different cohort of young and old mice. RM-ANOVA revealed that 
time spent exploring the objects decreased over the course of the three training sessions 
(F(2,78)=20.70, p<0.001) and the animals spent equal time exploring what would 
ultimately become the DO and NDO (F(2,78)=0.07, p=0.93), with no effect of age 
(F(2,38)=0.46, p=0.64). Three minutes after the last training session, the animals were 
returned to the training arena with one object displaced to a novel location. In this case, 
young and aged animals showed a preference for the DO (session: F(1,19)=20.49, 
p<0.001; session x age: F(1,19)=0.15, p=0.70), suggesting that acquisition of spatial 
memory was not affected by aging (Fig. 4.1C). Taken together, these results indicate 
that hippocampal function declines with age, causing impairments in the consolidation of 
long-term spatial memory.   
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To address whether these deficits are specific to the hippocampus and spatial memory, 
we assessed object recognition in young and old mice. We and others have shown that 
object recognition becomes independent of the hippocampus if the task is conducted 
with limited spatial cues (Forwood et al., 2005) or if the animals are familiarized to the 
context before training (Oliveira et al., 2010). We removed spatial cues from the walls 
and the animals were familiarized to the training arena for three consecutive days prior 
to training. On the fourth day, animals were placed into the same training arena 
containing 2 identical objects and allowed to explore for ten minutes. Twenty-four hours 
later, mice were re-introduced to the context containing one familiar object and one 
novel object (Fig. 4.2A). The relative preference for the novel object was calculated as 
the percentage of object exploration time dedicated to this object. Both young and old 
mice showed a preference for the novel object 24 hours after training (session: 
F(1,29)=25.67, p<0.001; session x age: F(1,29)=0.21, p=0.65), suggesting that object 
recognition is unaffected by aging (Fig. 4.2B).  
Discussion 
Using an object-place recognition task, we found that spatial memory consolidation is 
impaired in aged mice. Age-related cognitive decline can be difficult to characterize due 
to changes in motor activity (Gage et al., 1984; Markowska, 1999) and stress-related 
physiology and behaviors (Sparkman and Johnson, 2008) that can alter performance in 
spatial tasks (e.g., Barnes and  Morris water maze). Object-based tasks are 
advantageous because they are not physically demanding and they induce little stress. 
However, the requirement of the hippocampus for object-based memory (Forwood et al., 
2005; Oliveira et al., 2010) and retention length (Roozendaal et al., 2010) are known to 
vary with training protocol. For example, aging was found to impair both object-place and 
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novel-object recognition tasks when using relatively short training sessions (Murai et al., 
2007; Burke et al., 2010). Here we used two training protocols that produce robust long-
term memory and allow for the dissociation of hippocampal involvement. Extended pre-
exposure to the training context is known to reduce the role of the hippocampus in the 
novel object recognition task (Forwood et al., 2005; Oliveira et al., 2010). Thus, we 
provide a more direct examination of the effects of aging on spatial memory formation 
and consolidation.  
Previous attempts to rescue age-induced memory deficits have involved systemic 
injections of memory-enhancing compounds, (Davis et al., 1993; Markowska et al., 
1994; Bach et al., 1999; de Lima et al., 2005; de Lima et al., 2008; Rech et al.) often 
administered prior to training. A recent study found that injections of histone deacetylase 
(HDAC) inhibitors into the hippocampus prior to fear conditioning can rescue age-related 
contextual fear memory impairments (Peleg et al., 2010). Our findings raise the 
interesting possibility of enhancing hippocampal function immediately after training in 
order to ameliorate age-induced spatial memory impairments. 
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Figure Legends 
Figure 4.1. Aged mice have impaired long-term memory for object location. a) 
Diagram illustrating the experimental design for object place recognition. Animals were 
exposed to the context once for 10 minutes followed by three 10 minute training 
sessions with a 3 minute inter-trial interval. Testing occurred either 24 hours or 3 
minutes after the last training session by moving one of the objects to a new location. b) 
Bar graphs showing the percent preference for the displaced object (DO) at 24 hours for 
young (n=10) and aged (n=10) animals. c) Graphs showing the percent preference for 
the DO at 3 minutes for young (n=10) and aged (n=11) mice. Dotted line denotes 50% 
(chance) preference. * p<0.05. 
 
Figure 4.2. Aged mice show normal object recognition. a) Diagram illustrating the 
experimental design for object recognition. Animals were familiarized to the training 
context 10 minutes per day for 3 days prior to training. On the 4th day, 2 identical objects 
were introduced for 10 minutes. 24 hours later the animals were tested for object 
recognition by replacing one of the familiar objects with a novel object. b) Bar graphs 
showing the percent preference for the novel object in young (n=16) and old (n=15) 
animals. Dotted line denotes 50% (chance) preference. * p<0.05. 
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Chapter 5. Conclusions 
The studies described in this thesis have explored the molecular mechanisms that 
regulate sleep/wake and memory formation in mice and how these processes are 
altered by aging. In this chapter, I will review our primary findings, discuss some the 
questions that our findings have raised and describe future avenues of research for this 
work.  
 
CREB signaling is essential for the maintenance of wakefulness. 
In Chapter 2, we show that deletion of CREB in forebrain neurons reduces the ability to 
sustain wakefulness. The cerebral cortex is the common output of wake promoting brain 
regions such as the locus Coereleus (LC), the orexinergic neurons of the lateral 
hypothalamus and the dorsal Raphe nucleus (DR) (Saper, 2006; Datta and Maclean, 
2007). Interestingly, studies in rats show that pCREB levels increase in the cortex during 
wakefulness and decrease during sleep (Cirelli et al., 1996; Cirelli and Tononi, 2000). 
Our results suggest that this increase is functionally relevant to the maintenance of 
wakefulness. Consistent with this interpretation, constitutive deletion of 2 isoforms of 
CREB reduces wakefulness and wake-related cortical arousal (Graves et al., 2003b). It 
will be important to extend our studies and define the area(s) of the forebrain and the 
neuronal cells where CREB is required to sustain wakefulness. Our manipulations also 
caused deletion of CREB in the striatum, the hippocampus and the amygdala. However, 
the cholinergic basal forebrain, a known wake-promoting area, was spared in our 
experiments. Cortex-specific cre expressing lines, such as the Emx-driven Cre line 
(stock number 005628) available from Jackson labs, could be used to refine our findings. 
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Our laboratory has also recently acquired a mouse line where expression of Cre 
recombinase is restricted to layer VI of the cortex. It will be of interest to examine 
whether deletion of CREB from layer VI affects wakefulness because neurons 
expressing orexin-2 receptors in layer VIb are uniquely activated by the wake promoting 
peptide orexin (Bayer et al., 2004).  
 
Expression of Cre recombinase can be detected as early as E18.5 with high levels of 
expression at P5 in the forebrain Cre line that we used in Chapter 2 (Dragatsis and 
Zeitlin, 2000). Thus, we cannot exclude the possibility that developmental effects 
contribute to the phenotype that we observed. Viral approaches represent a promising 
avenue to address this concern. One potential limitation is the magnitude of the spread 
of infection, which could be problematic when targeting large areas such as the cortex. 
WPRE-mediated enhancement in viral infection (Klein et al., 2006), combined with 
multiple injection sites could be used to ensure that a large part of the cortex is covered. 
Another concern is that high levels of Cre expression can produce observable 
phenotypes and cause cellular toxicity (Forni et al., 2006). Thus, further experiments are 
needed to exclude the possibility that high levels of Cre expression in the forebrain can 
alter sleep/wake states. To address this potential pitfall, additional animals carrying only 
the Cre transgene should be characterized for sleep/wake patterns.  
 
Deletion of CREB is accompanied by compensatory increased expression of cAMP 
response element modulator (CREM), another member of the same family of 
transcription  factors (Hummler et al., 1994; Blendy et al., 1996; Rudolph et al., 1998; 
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Mantamadiotis et al., 2002; Parlato et al., 2006; Parlato et al., 2010). CREM is nearly 
undetectable in the brain under normal conditions and in the context of development and 
neurodegeneration, one allele of CREM is sufficient to restore some CREB function 
(Mantamadiotis et al., 2002). Thus, it would be of interest to explore the role of CREM 
upregulation in our experiments. One way to address this question would be to raise 
conditional CREB mutant animals on CREM deficient backgrounds. The prediction 
would be that CREM upregulation ameliorates CREB signaling and improve the 
behavioral phenotype that we observed, based on previous findings (Lemberger et al., 
2008; Parlato et al., 2010).  
 
The most studied and best characterized CREB signaling cascade requires 
phosphorylation of CREB and subsequent recruitment of co-activators, such as CREB 
binding protein (CBP) and p300 (Kwok et al., 1994; Lundblad et al., 1995; Mayr and 
Montminy, 2001; Johannessen et al., 2004). However, CREB-mediated transcription is 
also regulated in a phosphorylation-independent fashion via interaction with CREB-
regulated transcription coactivators (CRTCs) (Conkright et al., 2003; Takemori et al., 
2007; Xu et al., 2007). Furthermore, CRTC1, one of the three CRTC isoforms, is highly 
expressed in prefrontal cortex (Conkright et al., 2003), a region known to be important 
for high vigilance and arousal (Gompf et al., 2011). Because genetic deletion of CREB 
affects both phosphorylation dependent and independent pathways, additional studies 
are needed to determine which signaling cascade(s) is (are) required for the regulation 
of sleep/wake. CRTC mutants and animals carrying point mutations preventing the 
interactions between CREB and its co-activators represent promising strategies to tease 
out which activation pathway(s) are involved in the maintenance of wakefulness.  
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CREB-mediated gene transcription is exceedingly complex, and several distinct 
pathways are involved in translating external stimuli into alterations in the expression of 
CREB target genes. Much research has focused on identifying the CREB 
“transcriptome” (i.e. all of the genes regulated by CREB). Although CREB can bind to a 
few thousand gene promoters containing the consensus cAMP response elements 
(CRE) site, it is still unclear what fraction of these genes is functionally regulated by this 
interaction (Zhang et al., 2005). Furthermore, not all CRE sites are functional CREB 
targets, presumably because some of these are not be accessible within the chromatin. 
Importantly, the CREB transcriptome differs dramatically from cell type to cell type (Cha-
Molstad et al., 2004), indicating that CREB controls partially distinct subsets of genes 
within each brain region. Some in vivo work has focused on CREB target gene 
expression in the hippocampus or in the striatum (Bozon et al., 2003; Lemberger et al., 
2008) and their influence on behavior. However, few studies have examined 1) which 
CREB target genes are expressed in brain regions involved in the regulation of sleep 
and wake such as the cortex or 2) the functional relevance of the observed changes in 
cortical gene expression across sleep/wake (Cirelli et al., 1996; Cirelli and Tononi, 
2000). The conditional CREB mutant mice described in Chapter 2 would be a useful tool 
to begin addressing these questions. One major hurdle is the heterogeneity of cortical 
tissue, which limits our ability to detect small changes in gene expression using qPCR-
based approaches. In situ hybridization measurements could be used to address this 
issue, although these measurements can be technically difficult and tend to be less 
quantitative than qPCR.  
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What are the molecular mechanisms underlying age-related disruptions of 
sleep/wake? 
Phosphorylation of CREB at serine 133 is one of the key events regulating CREB-
mediated transcription (Figure 1.2). Studies show that both calcium homeostasis and 
calcium buffering (Foster et al., 2001; Toescu, 2007; Toescu and Vreugdenhil, 2010) are 
altered by aging, which could affect activity of calcium-calmodulin kinases (Xu et al., 
2010) and phosphorylation of CREB. Much of this work has focused on regions of the 
brain that are required for memory formation and little is known about how activity of 
these signaling cascades is altered by aging. In the cortex, PKA activity is lower in aged 
rats (Karege et al., 2001b) and our pilot studies suggest that pCREB levels are lower in 
aged mice compared to young adult animals (data not shown). In Chapter 2, we showed 
that CREB signaling in the forebrain is essential to the maintenance of wakefulness. In 
Chapter 3, we found that aged animals are unable to sustain long periods of 
wakefulness, similarly to mice lacking CREB in the forebrain. These observations raise 
several questions: 1) is CREB signaling reduced in the forebrain of aged mice? Our pilot 
studies indicate that pCREB levels are lower in the cortex of aged mice compared to 
young. 2) can age-induced fragmentation of wakefulness be rescued by increasing 
CREB signaling in the brain of aged mice? Several genetic tools are available to address 
this possibility. Our laboratory has developed viral approaches to express Gs coupled 
drosophila octopamine receptors, which could be use to increase cAMP signaling 
acutely in discrete areas of the brain. This construct could be injected in the cortex of 
aged mice to test the ability of increased cAMP signaling in rescuing long bouts of 
wakefulness in aged mice. Dr. Satoshi Kida has also developed a line of transgenic mice 
over-expressing CaMKIV (CaMKIV-OE), which increases pCREB levels (Fukushima et 
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al., 2008). One future direction would be to measure sleep/wake in young and aged 
CaMKIV-OE and control animals. Our prediction is that CaMKIV-OE animals will be 
resistant to the deleterious effects of aging on the ability to sustain wakefulness. 3) Does 
deletion of CREB in forebrain neurons occlude age-related fragmentation of 
wakefulness? Measuring sleep/wake in aged FB CREB cKO and control animals would 
address whether decreased CREB signaling is responsible for age-induced disruptions 
in sleep/wake.  
 
Molecular mechanisms of age-related cognitive decline.  
CREB-mediated transcription can be induced by several pathways including the 
cAMP/PKA and the calcium-CaMK kinase cascades (Figure 1.2). Interestingly, aging 
alters cAMP/PKA activity, calcium and CREB signaling in the brain (Zhang et al., 1996; 
Bach et al., 1999; Foster et al., 2001; Karege et al., 2001a; Karege et al., 2001b; Ramos 
et al., 2003; Brightwell et al., 2004; Hattiangady et al., 2005; Kudo et al., 2005; Monti et 
al., 2005; Ramos et al., 2006; Countryman and Gold, 2007; Fukushima et al., 2008; 
Loerch et al., 2008; Porte et al., 2008; Wang et al., 2010; Xu et al., 2010). pCREB levels 
are lower in the hippocampus and in the amygdala of wild-type aged animals (Brightwell 
et al., 2004; Kudo et al., 2005; Countryman and Gold, 2007; Porte et al., 2008) and in a 
mouse model of accelerated aging (Tomobe et al., 2007). Aging also causes changes in 
calcium homeostasis and calcium buffering (Foster et al., 2001; Toescu, 2007; Toescu 
and Vreugdenhil, 2010), which can lead to reduced CaMKIV activation (Qu et al., 2010). 
In addition, CaMKIV expression (Loerch et al., 2008) and protein levels (Fukushima et 
al., 2008) are reduced by aging. Pharmacological studies also indicate that cAMP 
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signaling is altered by aging (Bach et al., 1999; Mouravlev et al., 2006; Ramos et al., 
2006; Wang et al., 2010). However, cAMP levels in the aged brain have not been 
directly assayed to our knowledge, perhaps in part due to the technical difficulty of these 
experiments. Our pilot measurements indicate that baseline cAMP levels are lower in the 
hippocampus of aged (22-24 months) mice compared to young (2-4 months old, data not 
shown). Consistent with these observations, PKA activity is reduced in the hippocampus 
and in the cortex of aged rats (Karege et al., 2001a; Karege et al., 2001b). A prominent 
hypothesis in the literature is that altered activity of CREB activating cascades and 
reduced CREB signaling in the hippocampus and in the amygdala underlie age-related 
decline in cognition. Consistent with this hypothesis, CREB deficient mice seem to be 
more sensitive to age-related cognitive impairments (Hebda-Bauer et al., 2007), 
whereas boosting CaMKIV expression and p-CREB levels in the hippocampus of aged 
animals can rescue cognitive deficits (Fukushima et al., 2008). Experiments described in 
Chapter 4 have laid the groundwork for further exploration of the molecular 
underpinnings of age-related cognitive decline, by identifying where and when altered 
signaling is likely to impair memory formation. Our results indicate that signaling in aged 
animals is likely to be affected in the hippocampus during memory consolidation. Studies 
suggest that consolidation of object-related memories occurs during the 4-6 hours 
following training (de Lima et al., 2006; Oliveira et al., 2010). Thus, future studies should 
focus on measuring cAMP, pCREB and PKA activity in the hippocampus in the hours 
following training on object tasks. Intra-hippocampal pharmacological manipulations 
aimed at rescuing age-induced spatial memory deficits would address the functional 
relevance of the changes in CREB signaling in the brain of aged mice. An alternative 
approach is the use of light-activated adenylyl cyclase (Schroder-Lang et al., 2007) or 
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transgenic approaches using the Gs-coupled drosophila octopamine receptors in the 
hippocampus to temporarily increase cAMP signaling in the hippocampus.  
 
Sleep deterioration and impaired memory formation with aging. 
The function of sleep remains one of science’s unanswered questions and a topic of 
ongoing debate. What is clear is that sleep can improve memory formation (Marshall et 
al., 2004; Walker and Stickgold, 2006) and that sleep deprivation negatively impacts 
cognition (Graves et al., 2003a; Palchykova et al., 2006; Halassa et al., 2009; 
Palchykova et al., 2009; Hagewoud, 2010; Hagewoud et al., 2010; Florian et al., 2011). 
A recent study shows that the integrity (i.e. the architecture) of sleep is important for 
memory consolidation (Rolls et al., 2011). In Chapters 3 and 4, we found that aging 
affects both sleep/wake and memory consolidation. One question that has proven 
difficult to address is the relationship between deficits in memory formation and sleep 
disturbances in the elderly. The rescue experiments described above could be one way 
to tease out whether these two phenomena are linked.  
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